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ABSTRACT

Author: Marshall, Mary, E. PhD
Institution: Purdue University
Degree Received: August 2018
Title: Do You Smoke?: How Physicians Navigate Conversations about Smoking and Lung
Cancer
Major Professor: Cleveland Shields
Lung cancer, the second most commonly diagnosed cancer, is a leading cause of death
among older adults (Cronin et al., 2018; Siegel, Miller, & Jemal, 2017). While there are
numerous health benefits associated with smoking cessation in patients with advanced lung
cancer (Gemine & Lewis, 2017; Parsons, Daley, Begh, & Aveyard, 2010), conversations about
smoking cessation are infrequent and often lack physician support for cessation (Warren,
Marshall, et al., 2013; Wells et al., 2017). Physicians may avoid lengthy conversations about
smoking to protect patients from feeling shame and guilt due to the perceived stigma associated
with smoking and a lung cancer diagnosis (Champassak et al., 2014; Wells et al., 2017).
However, given that conversations about smoking increase patients’ success rates with smoking
cessation (Stead, Bergson, & Lancaster, 2013), it is important to examine how physicians can
tailor conversations about smoking to patients with lung cancer taking stigma into consideration.
Thus, the primary aim of this study was to examine the current state of conversations about
smoking with patients with lung cancer, for the purpose of providing an account of the
communication behaviors that are present, and suggestions for communication behaviors that
may be lacking.
To examine how physicians navigate conversations about smoking with patients with
lung cancer, qualitative content analysis was performed on 58 transcripts of conversations
recorded during an initial appointment with a standardized patient. We found that a majority of

x
physicians initiated conversations about smoking, often during the medical history charting
process or during conversations about the lung cancer diagnosis. The content of conversations
about smoking generally fit within six categories: assesses smoking status, builds smoking
history profile, praises smoking cessation, connects smoking behaviors to diagnosis or treatment,
provides empathy or understanding, and presents a negative bias about smoking. Finally,
approximately one-third of physicians provided emotional support for smoking cessation or
smoking-related stigma. Findings indicate that while a majority of physicians ask patients about
smoking, most physicians aimed for these conversations to be short, routine, and medically
driven. Therefore, conversations about smoking were not tailored to meet the specific needs of
patients with lung cancer, which might include additional provision of support for smoking
cessation and recognition of smoking-related stigma.
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW

Lung cancer is the second most commonly diagnosed cancer and accounts for about 25%
of new diagnoses each year (Cronin et al., 2018; Siegel et al., 2017). Lung cancer is the leading
cause of cancer death among men and women, particularly among older adults, partially because
symptoms leading to a diagnosis do not appear until the cancer is in an advanced stage (Siegel et
al., 2017). Nearly 90% of lung cancer diagnoses are linked to smoking behaviors (Park et al.,
2012), and up to 30-50% of patients with cancer continue smoking after a diagnosis (Cooley et
al., 2009; Guimond et al., 2017). While there are numerous health benefits associated with
smoking cessation in patients with advanced lung cancer (Gemine & Lewis, 2017; Parsons et al.,
2010), conversations about smoking cessation are infrequent and often lack physician support for
cessation (Warren, Marshall, et al., 2013; Wells et al., 2017). Physicians may avoid lengthy
conversations about smoking to protect patient’s from feeling shame and guilt due to the
perceived stigma associated with smoking and a lung cancer diagnosis (Champassak et al., 2014;
Wells et al., 2017), and indeed patients report feeling shame and stigma during interactions with
physicians (Shen, Hamann, Thomas, & Ostroff, 2016; Tod & Joanne, 2010). However, given that
conversations about smoking increase patients’ success rates with smoking cessation (Stead et
al., 2013), it is important to understand how physicians can tailor conversations about smoking to
patients with lung cancer taking smoking-related stigma into consideration. Thus, this study
begins this exploration with an examination of the current state of conversations about smoking
with patients with lung cancer, for the purpose of providing an account of the communication
behaviors that are present, and suggestions for communication behaviors that may be lacking.
Survival rates and longevity for lung cancer have been steadily rising in recent years, and
given that patients are now living longer with this disease, it is important to focus on higher
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quality of life and well-being for patients (Cronin et al., 2018). Given that up to 90% of patients
with lung cancer currently or previously smoked (Park et al., 2012), several medical associations
are encouraging physicians to initiate conversations about smoking with every patient with lung
cancer (Hanna, Mulshine, Wollins, Tyne, & Dresler, 2013; Toll, Brandon, Gritz, Warren, &
Herbst, 2013). However, currently there is little research on how physicians navigate
conversations about smoking, which may be a particularly sensitive conversation for patients
with lung cancer because of smoking-related stigma. Smoking-related stigma can have numerous
negative health outcomes for patients with lung cancer including delays in seeking medical care
(Carter-Harris, Hermann, Schreiber, Weaver, & Rawl, 2014; Tod, Craven, & Allmark, 2008),
increased psychological distress (Brown Johnson, Brodsky, & Cataldo, 2014; Cardoso, Graca,
Klut, Trancas, & Papoila, 2016), and reduced quality of life (Hamann et al., 2014; Shen et al.,
2016). Fortunately, physicians can support patients with lung cancer during conversations about
smoking by using empathic communication that can help build patient resilience to stigma
(Hamann et al., 2014; Morse, Edwardsen, & Gordon, 2008; Shen et al., 2016). Satisfactory
physician-patient communication can buffer the effects of stigma on patients, thus researchers
are developing training modules to increase empathic, non-judgmental communication skills for
physicians that work with patients with smoking-related diseases such as lung cancer (Riley,
Ulrich, Hamann, & Ostroff, 2017). Therefore, research that explores the current state of
physician-patient communication about smoking can provide foundational knowledge for
communication interventions.
However, many of the studies that examine smoking-related stigma with patients with
lung cancer have focused on patient or physician perception of stigma, through the use of
surveys, interviews, and focus groups (i.e. (Brown Johnson et al., 2014; Chapple, Ziebland, &
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McPherson, 2004a; Farley, Aveyard, Kerr, Naidu, & Dowswell, 2016). Observational research
regarding how physicians navigate sensitive topics often associated with stigma, such as
smoking, within cancer management appointments is lacking. While physicians have the ability
to mitigate negative effects of stigma through empathic communication (Hamann et al., 2014;
Shen et al., 2016), we do not know much about the content and progression of conversations
about smoking, particularly regarding how physicians may tailor conversations specifically for
patients with lung cancer. Understanding how physicians navigate conversations about smoking
with patients with lung cancer is an important step in improving patient well-being and health
outcomes through improved physician-patient communication.
Research Questions
Observational research to uncover how conversations about smoking naturally unfold
would improve understanding about how physicians choose to initiate and navigate
conversations about smoking in the context of advanced lung cancer. Therefore, the aim of this
study is to explore strategies physicians use to discuss smoking with standardized patients
presenting with lung cancer. The use of a covert standardized patient model, allows for: a) our
actors to present as a patient with similar demographic characteristics, diagnosis, and smoking
history, and b) a more natural response from the physician as they are unaware they are being
observed (i.e., the “Hawthorne effect”; Srinivasan et al., 2006; Zabar et al., 2014). Patient factors
such as health status, income level, ethnicity, gender and more may influence level of care
provided by physician, therefore using standardized patients allows for control over patient
factors (Srinivasan et al., 2006). Additionally, physicians that are made aware they are being
recorded are more likely to provide higher level of care than normal because they are aware they
are being judged for their behaviors, therefore using unannounced visits allows for observing
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physician’s usual level of care (Zabar et al., 2014). The aim of this study is to use observational
methods to examine how physicians navigate conversations about smoking with a common
stimulus, a male patient with advanced lung cancer and a history of smoking. A qualitative
content analysis of conversations will address the following questions:
1. How and when do physicians initiate conversations about smoking?
2. How do physicians proceed through conversations about smoking?
3. How do physicians provide support for smoking cessation or smoking-related stigma?
Literature Review
Patients with lung cancer face a unique contextual factor that patients with other types of
cancers may not encounter; the historical background of smoking in the United States and how
that influenced smoking-related stigma at the societal level. Physicians should be aware of the
historical context of smoking in the United States as it may influence how they navigate
conversations about smoking with patients with lung cancer. Understanding that smoking-related
stigma may produce feelings of guilt and shame in patients (Chambers et al., 2012; Hamann et
al., 2014), meaning that physicians may need to tailor their conversations about smoking
differently for patients with lung cancer. This chapter will examine the historical context of
smoking in the United States, smoking-related stigma, smoking cessation behaviors among
patients with lung cancer, and physician-patient communication behaviors.
Historical Context of Smoking in the US
As early as the 1960’s, we understood the causal connection between smoking and
various negative health outcomes. A committee was formed by the Department of Health to
review a number of studies about smoking and health and they concluded: “In view of the
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continuing and mounting evidence from many sources, it is the judgment of the Committee that
cigarette smoking contributes substantially to mortality from certain specific diseases and to the
overall death rate” (U.S. Department of Health, Education, and Welfare, 1964, pg. 31). However,
despite the historic report from the U.S. Department of Health stating that smoking was
hazardous to health, the general public perception of smoking was still often associated with
glamour, pleasure, and socialization (Castaldelli‐Maia, Ventriglio, & Bhugra, 2015). The use of
tobacco was promoted through a variety of outlets, including print advertisements, television
shows, and films using celebrity figures to endorse particular brands (Castaldelli‐Maia et al.,
2015; Proctor, 2004). Even physicians and nurses were involved in advertising for tobacco use,
with the public trusting their authority and credibility as medical professionals (Gardner &
Brandt, 2006). Advertisements made claims that smoking had numerous health benefits such as
reducing weight gain and anxiety (Gardner & Brandt, 2006; Proctor, 2004). Additionally, during
this time period, there were no large-scale policies preventing smoking in public locations
(Castaldelli‐Maia et al., 2015), which helped it become a publicly accepted behavior. Tobacco
companies worked to prevent information about the hazards of smoking from reaching the
general public, and therefore many individuals continued to start smoking even after evidence of
negative health outcomes were being shared by health organizations (Castaldelli‐Maia et al.,
2015; Gardner & Brandt, 2006; Proctor, 2004).
However, as more medical associations, such as the Journal of American Medical
Association and American Medical Association, began to disseminate the hazards of smoking,
public health efforts were initiated to reduce smoking by decreasing the social acceptability of
the behavior (Gardner & Brandt, 2006). Public health groups utilized advertising campaigns
drawing on fear of diseases from smoking and instated smoke-free areas to make smoking in
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public more challenging (Alamar & Glantz, 2006; Bell, Bowers, McCullough, & Bell, 2012).
While these efforts have been successful at reducing the rates of smoking, they may have also
increased stigma surrounding smoking (Chapple, Ziebland, & McPherson, 2004; Stuber, Meyer,
& Link, 2008). Along with anti-smoking media campaigns that attribute responsibility to those
who have smoked (Leveälahti, Tishelman, & Öhlén, 2007), limited research funds and advocacy
efforts, and lack of support groups for patients with lung cancer may also contribute to feelings
of stigma (Knapp-Oliver & Moyer, 2012; Siminoff, Wilson-Genderson, & Baker, 2010). Taking
into considering the historical context of smoking, the United States currently has a cohort of
older adults that has lived through this shift in perception about smoking. Current older adults
grew up during a time when smoking was glamourized and advertised heavily, and now they are
faced with diseases such as lung cancer and the associated stigma. Older adult patients with lung
cancer report that they began smoking during a time when it was considered socially acceptable,
and feel upset that they are now being blamed for their disease when the hazards of smoking
were not widely known when they began smoking (Chapple et al., 2004). Other older adult
patients with lung cancer express doubts about the link between smoking and lung cancer (Wells
et al., 2017), possibly from being exposed to early advertising that promoted the benefits of
smoking. Therefore, it is important to consider the patient’s historical context of smoking, as it
may influence feelings toward smoking cessation and smoking-related stigma.
Stigma and Lung Cancer
Patients with lung cancer may face many challenges throughout diagnosis, treatment, and
management of the disease. Depending on the type and stage of the cancer, treatment may
include surgery, chemotherapy, or radiation therapy. However, for late-stage lung cancer,
treatments are generally to assist patient comfort and extend life for a short duration, not to cure
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the disease. Treatments for lung cancer may be chosen to extend life and increase comfort by
shrinking tumor size, but such treatments often have severe side effects that may negatively
affect quality of life (Akin, Can, Aydiner, Ozdilli, & Durna, 2010; Usta, 2012). Compared to
other cancers, patients with lung cancer report higher symptom burden (Cataldo, Dubey, &
Prochaska, 2010), including depressive symptoms, fatigue, pain, and reduced quality of life (Fox
& Lyon, 2006). Additionally, they report higher distress levels and lower well-being compared to
other cancers, which may be attributed to the poor prognosis (Cardoso et al., 2016; Vodermaier,
Linden, MacKenzie, Greig, & Marshall, 2011), and perception of stigma and guilt associated
with lung cancer (Carter-Harris et al., 2014; Lebel et al., 2013). Patients with lung cancer report
feeling stigmatized due to the known association between smoking and cancer (Brown Johnson
et al., 2014; Cataldo, Jahan, & Pongquan, 2012), which is a challenge unique to lung cancer.
Stigmatization is the process of discrediting or devaluing an individual because of a
personal attribute or behavior considered socially undesirable because it goes against societal
norms (Goffman, 2009; Link & Phelan, 2001). These attributes are generally related to a
personal characteristic or diagnosis of a medical condition that is identified by society to be
deviant or self-inflicted (Goffman, 2009). Stigma exists as a way to regulate personal behaviors
to fit societal norms by encouraging conformity and discouraging deviant behavior, often by
means of ‘shaming’ particular unhealthy behaviors (Burris, 2002; Roberts & Weeks, 2017). In
the case of lung cancer, the strong association between smoking and lung cancer has created an
environment where patients often feel stigmatized by the public, regardless of prior smoking
history (Chapple et al., 2004; Sun, Schiller, & Gazdar, 2007). Stigma is a socially constructed
concept learned through interactions, and works through social processes such as stereotyping,
cognitive dissonance, and emotional response to individuals (Yang et al., 2007). Stigmatized
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views can negatively influence emotional responses (i.e. prejudice), as well as behaviors (i.e.
discrimination; Yang et al., 2007), and can be overt (i.e. avoidance, rejection) or subtle (i.e. lack
eye contact) in nature (Bos, Pryor, Reeder, & Stutterheim, 2013).
While stigma often occurs at the interpersonal level, it is important to understand that
individuals exist within a larger social, cultural, and political context that shape their values and
perceptions. Therefore, stigma goes beyond interpersonal interactions to influence individuals at
a structural level. Structural stigmatization is driven by decision-makers at higher levels that
implement policies that negatively affect a particular group identified with a stigmatizing
attribute by society (Yang et al., 2007). Social, economic, and political policies that promote
structural stigmatization may reduce opportunities, limit rights, and endorse status loss or
discrimination for stigmatized individuals (Yang et al., 2007). Structural stigmatization may
affect individuals facing stigma for medical conditions, such as lung cancer, with policies that
reduce research funding, public health advocacy, and support for patients (Link & Phelan, 2001;
Yang et al., 2007). Carter & Nguyen (2012), found that lung cancer was underfunded in relation
to societal burden (cost, mortality), attributing lack of funding to stigma. Further, structural
stigmatization also occurs in the public health domain through ads aimed at shaming and
degrading smoking behaviors, and often those who smoke (Riley et al., 2017).
To understand the role of stigma in lung cancer, it is important to go beyond the
foundational definition of the concept and explore how perceptions regarding the personal
responsibility for having a stigmatizing condition are influential. Gerhard Falk (2001) identified
two types of stigma: 1) existential stigma, in which a person has little control over their
circumstances (i.e. age), and 2) achieved stigma, in which a person is believed to have
contributed to their circumstances (i.e. addiction). This is similar to the concept, onset
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controllability, which is how much an individual is considered personally responsible for their
stigmatized position because of deviant behaviors (Bos et al., 2013). It is theorized that
individuals that are perceived to have personal responsibility for their condition, such as patients
with lung cancer who have smoked, will face higher rates of stigma and lower levels of support
and sympathy (Bos et al., 2013; Goffman, 2009). In fact, Sriram et al. (2015), found that patients,
caregivers, physicians, and the general public demonstrate more negative implicit biases
regarding patients with lung cancer such as negativity, despair, and shame, compared to more
positive views of patients with breast cancer. Additionally, these same participants showed a
strong association between smoking behaviors and lung cancer, indicating that they understand
that smoking is often associated with a lung cancer diagnosis (Sriram et al., 2015). Across
various outlets, including news articles (Riles, Sangalang, Hurley, & Tewksbury, 2015),
individuals from the general public (Bresnahan, Silk, & Zhuang, 2013; Marlow, Waller, &
Wardle, 2015), and oncology nurses (Wang, Zhan, Zhang, & Xia, 2015), patients with lung
cancer are perceived to carry responsibility for their illness. Overall, because patients with lung
cancer are often perceived as responsible for their diagnosis, they may experience increased
stigma compared to other cancer types (Lebel et al., 2013; LoConte, Else-Quest, Eickhoff, Hyde,
& Schiller, 2008; Stuber et al., 2008).
Across a variety of studies a majority of patients with lung cancer report feeling
stigmatized (Chambers et al., 2012), with half reporting medical professionals as a source of
feelings of stigma (Shen et al., 2016). Additionally, patients with lung cancer report higher levels
of stigma compared to other cancer types (Lebel et al., 2013; LoConte et al., 2008). The stigma
associated with lung cancer can have many deleterious effects on patient health both short-term
and long-term. Patients report that stigma is a primary reason that they delay seeking healthcare
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when they first have symptoms related to lung cancer, this results in a delay in diagnosis which
may render some treatment options less beneficial (Carter-Harris et al., 2014; Chambers et al.,
2012). Longevity of life is higher among patients diagnosed at earlier stages of lung cancer, with
diagnoses occurring before stage 4 substantially increasing the 1-year survival rate (McPhail,
Johnson, Greenberg, Peake, & Rous, 2015). However, when patients delay seeking healthcare
when symptoms first arise, they are more likely to be diagnosed at an advanced stage (Siegel et
al., 2017). Additionally, patients with lung cancer that feel stigmatized report higher levels of
physical symptom severity (Cataldo & Brodsky, 2013).
Over time individuals with stigmatizing conditions become perceptive to the stigma they
experience and can become predisposed to anticipate stigma, rejection, discrimination, and bias
(Bos et al., 2013; Yang et al., 2007). Some individuals cope with anticipated stigma by
disengaging with contexts that may be stigmatizing, such as medical facilities (Bos et al., 2013).
Many patients avoid healthcare because they worry they will be turned away (Chapple, Ziebland,
& McPherson, 2004; Corner, Hopkinson, & Roffe, 2006) or blamed for their disease (Tod &
Joanne, 2010). Patients may choose to conceal their smoking status from healthcare providers for
fear of being judged (Stuber & Galea, 2009). Additionally, some patients may not seek support
from family or friends due to disease stigma (Chapple, Ziebland, & McPherson, 2004; Conlon,
Gilbert, Jones, & Aldredge, 2010), going as far as to not reveal their cancer type to loved ones
which can create feelings of social isolation (Berterö, Vanhanen, & Appelin, 2008; Carter-Harris,
2015; Hamann et al., 2014). Patients with lung cancer who feel stigmatized report a decreased
desire to be involved in treatment decision-making because they perceive themselves as ‘poor
decision-makers’ (Hamann et al., 2014).
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Many studies have explored the negative effects of stigma on mental health and quality of
life (i.e. Brown Johnson et al., 2014; Cataldo et al., 2012; Hamann et al., 2014; Shen et al.,
2016). Rates of lung cancer stigma are associated with elevated depressive symptoms (Cataldo &
Brodsky, 2013; Chambers et al., 2015; Gonzalez & Jacobsen, 2012), elevated anxiety (Cataldo &
Brodsky, 2013; Chambers et al., 2012; Chapple et al., 2004), and emotional distress (Hamann et
al., 2014). Further, the association between stigma and elevated levels of psychological distress
is higher for lung cancer compared to other cancer types (Lebel et al., 2013). Stigma may be
associated with poorer psychological outcomes through the pathway of feeling personally
responsible for their illness. Patients who believe they are responsible for their illness report
higher distress levels (Else-Quest, LoConte, Schiller, & Hyde, 2009), and patients with lung
cancer report higher rates of feeling responsible for their illness compared to patients with breast
cancer or prostate cancer (Else-Quest et al., 2009; LoConte et al., 2008). Both those who
currently smoke and who have previously smoked struggle with feelings of guilt for “causing”
the disease and not seeking medical care as soon as symptoms arose (Berterö et al., 2008). This
escalation of blame and guilt, both internal and external, may increase feelings of social isolation
(Brown Johnson et al., 2014; Chambers et al., 2015) and depression (Schmidt et al., 2006).
Further, physicians may hold stigmatized views of patients with lung cancer, which may
negatively impact patient-physician communication and overall relationship satisfaction
(Gonzalez & Jacobsen, 2012; Hamann et al., 2014; Stuber, Meyer, & Link, 2008). Physicians
and healthcare professionals report being aware of the stigma that patients with lung cancer face,
and how stigma may influence referral patterns for treatments like chemotherapy and radiation
for patients with lung cancer (Tran et al., 2015). The association between smoking and lung
cancer may influence negative perceptions physicians have about patients with lung cancer,
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which may translate to using negative or stigmatizing language during appointments with these
patients. Physicians have more pessimistic views regarding lung cancer compared to other types
of cancer; they are less likely to refer patients with lung cancer for chemotherapy (Wassenaar et
al., 2007), report that lung cancer is more difficult to treat, and that patients with lung cancer
have poorer quality of life and more symptoms (Hamann et al., 2013). Having a bleak
perspective about health outcomes and quality of life for patients with lung cancer could
contribute to a negative bias in how physicians communicate particular treatment options, such
as smoking cessation. If physicians perceive the disease as self-inflicted because patients make
poor behavioral health choices, they may believe that patients will be non-adherent to treatment
options (Warren, Marshall, et al., 2013; Wassenaar et al., 2007).
While patients with lung cancer report stigma regardless of their smoking history
(Cataldo et al., 2012; Sun et al., 2007), those with a history of smoking report higher levels of
guilt and shame (LoConte et al., 2008), and identify stigma as an obstacle to seeking lung cancer
screenings (Carter-Harris, 2015). In qualitative studies, patients with lung cancer have identified
smoking as a source of stigmatization (Tod & Joanne, 2010), including discussion of smoking
during medical appointments (Simmons et al., 2009). Further, when researchers developed a new
measure of stigma in lung cancer, four factors emerged: shame, social isolation, discrimination,
and smoking (Cataldo, Slaughter, Jahan, Pongquan, & Hwang, 2011). Given that patients
identify smoking as a source of stigma, and stigma is associated with poorer patient health and
well-being, it is important to consider how physicians navigate conversations about smoking
with patients with lung cancer.
The historical context of the stigma surrounding smoking and lung cancer provides a
deeper understanding of the internal processes at work for both physicians and patients during
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lung cancer appointments. Stigma theory suggests that because patients with lung cancer are
stigmatized by society, both physicians and patients may be entering the appointment with
preconceived ideas about the role of smoking in relation to the disease (Bayer, 2008; Chapple,
Ziebland, & McPherson, 2004). Additionally, an encompassing review of the literature indicates
that stigmatized individuals, particularly those that are believed to be responsible for their illness,
face increased negative attitudes and possible negative health consequences (Lebel & Devins,
2008). Therefore, because smoking is a source of stigma for patients with lung cancer,
physicians should approach the discussion of this topic sensitively.
Smoking Cessation in Patients with Cancer
Addressing smoking behaviors is an important consideration in advanced lung cancer
management. While many patients attempt to quit smoking shortly after being diagnosed with
cancer (Kashigar et al., 2013), anywhere from 30-50% of patients continue smoking after
diagnosis and treatments (Cooley et al., 2009; Cox, Africano, Tercyak, & Taylor, 2003;
Guimond et al., 2017). Continued smoking after a lung cancer diagnosis is associated with higher
pain levels (Daniel et al., 2009), depressive symptoms (Berg et al., 2013), increased risk of
cancer recurrence (Parsons et al., 2010), increased side effects following radiation treatment
(Conlon, Pattinson, & Hutton, 2017), and all cause mortality (Parsons et al., 2010; Warren,
Kasza, Reid, Cummings, & Marshall, 2013). Patients undergoing lung cancer surgery who
continued smoking faced higher risk of death or health complications following surgery (Gajdos
et al., 2012; Mason et al., 2009).
Research continues to reveal the benefits of smoking cessation, even following a cancer
diagnosis (Cataldo et al., 2010; Gemine & Lewis, 2017; Shen et al., 2015). Smoking cessation in
patients with lung cancer is associated with both short-term and long-term benefits such as
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improved oxygen flow and energy levels, and reduced blood pressure and risk of tumor growth
(Cataldo et al., 2010). It is also associated with improved prognostic survival rates (Gemine &
Lewis, 2017; Nia et al., 2005; Parsons et al., 2010), with findings indicating that even quitting at
the time of diagnosis can considerably improve prognosis (Gemine & Lewis, 2017; Nia et al.,
2005). Patients that remain abstinent show better emotional and social functioning, higher levels
of quality of life, and reduced symptoms after treatments (Conlon et al., 2017). For patients with
lung cancer who feel stigmatized, using positive thinking strategies is a buffer for the negative
effects of stigma, but only for patients who have quit smoking (Shen et al., 2015). Therefore,
addressing smoking during lung cancer management is important to improving patient wellbeing and prognostic survival rates.
While many patients report they quit smoking shortly after a lung cancer diagnosis
(Kashigar et al., 2013), half of all patients that attempt smoking cessation face relapse (Guimond
et al., 2017; Walker et al., 2006), even up to one year after quitting (Cooley et al., 2009). Patients
report numerous personal barriers to smoking cessation during cancer, including the stress of a
diagnosis, desire to remain in control of their life, and lack of acceptance that there is a link
between smoking and cancer diagnosis (Wells et al., 2017). Some patients report using smoking
as a coping mechanism to deal with the stress of the diagnosis (Farley et al., 2016; Simmons et
al., 2009), or feel pessimistic about the benefits of quitting since they have already been
diagnosed with cancer (Farley et al., 2016).
Patients also report structural barriers to smoking cessation, including lack of physician
support and access to medications. Only half of patients attempting to quit smoking use formal
support such as prescribed medication (Cooley et al., 2009; Schnoll et al., 2004), while less than
half use informal support such as over-the-counter nicotine patches (Schnoll et al., 2004).
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Patients that use pharmaceutical support for smoking cessation, such as patches or pills, are more
likely to remain abstinent (Simmons et al., 2009). Patients with cancer report a lack of
meaningful discussion about smoking cessation, noting that physicians rarely provided
information or referral to cessation services (Simmons et al., 2009; Wells et al., 2017). While
some physicians describe having smoking conversations with many of their patients, they
acknowledge discussing cessation medications in less than half of their appointments (Warren,
Marshall, et al., 2013). Further, both patients and physicians report that there is inadequate
follow-up at future appointments regarding smoking cessation (Simmons et al., 2009), even
though follow-up conversations about cessation are associated with reduced relapse rates
(Okuyemi, Nollen, & Ahluwalia, 2006; Park et al., 2015).
Physicians can have a positive impact on smoking cessation, in a meta-analysis, (Stead et
al., 2013) found that even brief communication about cessation (e.g. less than 20 minutes) was
beneficial for preventing relapse up to 18 months after quitting. Additionally, out of a variety of
tactics physicians can use to help patients with smoking cessation, Park et al., (2015), found that
assisting the patient with making a quit plan (i.e. set a quit date, recommend medications,
provide self-help materials), and arranging a follow-up plan (i.e. setting a follow-up
appointment, plan for contacting via phone or email) were associated with a 40% increased odds
of smoking cessation. However, many physicians do not engage in these tactics as they are more
intensive than other tactics such as asking about tobacco use or advising patients to quit (Park et
al., 2015). Additionally, when physicians receive training for smoking cessation, their patients
report improved short-term cessation rates (Brose, West, Michie, & McEwen, 2014). Multiple
health organizations have recognized the importance of smoking cessation for patients with
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cancer and released policy statements that endorse providing more cessation assistance to
patients with all types of cancer at all stages of disease (Hanna et al., 2013; Toll et al., 2013).
Physician Communication about Smoking
Given that patients with lung cancer may experience smoking-related stigma, prompting
feelings of shame and guilt, conversations about smoking can be challenging for both physicians
and patients (Chapple et al., 2004; LoConte et al., 2008). Therefore, physicians often structure
conversations about smoking to be short and part of the routine of charting medical history to
avoid difficult discussions about the emotional response to smoking while having lung cancer
(Wells et al., 2017). While some physicians believe that smoking cessation is a critical part of
lung cancer management that they address with each patient (Warren, Marshall, et al., 2013),
other physicians report that they wait for patients to initiate discussions about smoking (Bell et
al., 2012). Overall, physicians are less likely to provide advice or prescribe medications to assist
with cessation for patients with cancer compared to those with other illnesses, such as coronary
heart disease (Farley et al., 2017). Patient perceptions of good communication with their
physician (e.g., explaining things in a way that is easy to understand, listening carefully,
knowing medical history, showing respect) is associated with lower levels of stigma for patients
with lung cancer (Shen et al., 2016). Therefore, addressing emotionally charged topics, such as
smoking, in a sensitive manner may be particularly important for physicians caring for patients
with lung cancer.
Physicians report a variety of barriers that influence conversations about smoking, such
as limited time during appointments (Bell et al., 2012; Champassak et al., 2014; McIlfatrick,
Keeney, McKenna, McCarley, & McElwee, 2013) and lack of training (Conlon et al., 2017;
Wells et al., 2017). Physicians voice concern that sensitive conversations may damage the
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relationship they have with their patients (Champassak et al., 2014; Wells et al., 2017), even
though patients regard physicians who discuss smoking cessation more positively on patient
experience measures (Winpenny et al., 2017). Physicians worry that patients may react poorly to
discussion about smoking (Chapple et al., 2004), and they do not feel trained to provide patients
with coping strategies or other cessation support services (Chapple et al., 2004; Warren,
Marshall, et al., 2013; Wells et al., 2017). Aware of their position of authority, physicians are
cautious to “lecture”, “preach”, or “police” their patients’ behaviors (Champassak et al., 2014;
Wells et al., 2017). Further, some physicians weigh the benefit of smoking cessation against
patient stress and mental health and wonder if promoting cessation is beneficial, particularly for
patients with a short prognosis (Wells et al., 2017).
Whether they intend to or not, physicians may engage in communication behaviors that
exacerbate stigma. Physicians may convey stigmatizing messages to their patients by using
critical or judgmental language when talking about smoking (Morse et al., 2008; Riley et al.,
2017). Language that blames the patient, suggests that smoking caused the disease (Morse et al.,
2008; Riley et al., 2017; Weiss, Ramakrishna, & Somma, 2006), or indicates that patients had
complete control over their behaviors and deserve the illness (Hamann et al., 2014; Smith, 2007),
can intensify stigma. For example, when patients with lung cancer express guilt, some physicians
not only disregard these concerns but use critical language directed toward the patient such as,
“your smoking’s done a number on your lungs” (Morse et al., 2008, p. 1855), or “that’s what you
get for smoking” (Hamann et al., 2014, p. 84). Further, stigma may be increased by implying that
the inability to provide treatment is due to the patient’s past smoking behaviors (Morse et al.,
2008), or expressing a pessimistic attitude toward treatment options for patients with a history of
smoking (Hamann et al., 2014).
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Asking patients recently diagnosed with lung cancer about their smoking habits, even for
those who do not smoke, can make patients feel defensive, guilty, or judged (Hamann et al.,
2014). Particularly if asking about their smoking behavior occurs early in the conversation, as
one patient reported in a qualitative interview, “Because the first thing they ask is…did you
smoke?” (Hamann et al., 2014). Many physicians report that they only discuss smoking as one
question on a long list about their lifestyle behaviors, and often do not take the conversation any
further than asking “do you smoke?” (Wells et al., 2017). Stigmatized individuals may be
sensitive to statements that reinforce negative perceptions or stereotypes of those who smoke
(e.g., choice versus addiction, perceived lower education of those who smoke, etc…). Therefore,
physicians should be aware that their negative attitudes towards patients with a history of
smoking may be associated with use of negative language to describe patients who currently or
previously smoked (Smith, 2007). Additionally, patients report that using coercion to promote
smoking cessation is a tactic that influences negative attitudes toward themselves and their
illness (Bell et al., 2012; van Eerd, Risør, van Rossem, van Schayck, & Kotz, 2015), particularly
if a physician uses language associated with personal values or morality (Smith, 2007).
Physicians can also engage in communication behaviors that buffer the negative effects
of stigma. Using person-first language can reinforce the idea that the patient is more than just
their behavior. For example, rather than saying “smokers”, physicians can use language such as,
“patients with a smoking history” to emphasize that the patient has attributes other than smoking
(Smith, 2007). Messaging that moves the sense of sole responsibility away from the patient and
onto other sources can be helpful. Physicians can acknowledge the role of nicotine addiction
(Bell et al., 2012), and the successful marketing techniques of the tobacco industry (Hamann et
al., 2014; Riley et al., 2017), when discussing the patient’s smoking history. Physicians may
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work to “challenge the public understanding of stigma by deferring agency/control away from
the stigmatized individual” (Meisenbach, 2010, p. 17), by shifting the focus away from the
stigmatizing behavior being the sole aspect of their identity.
Promoting peer support groups can provide confirmation of support for those with lung
cancer to remind patients that they are not alone or undeserving of care (Hamann et al., 2014;
Weiss et al., 2006). Moreover, physicians can offer personal support, coping mechanisms, and
positive reinforcement, which can help patients deal with feelings of stigmatization. (Cataldo et
al., 2010; Wells et al., 2017). Providing credible and accurate evidence-based information can
reduce stigma as it removes morality and personal belief from the conversation (Bell et al., 2012;
Riley et al., 2017). In particular, using gain-framed messages that highlight the benefits of
quitting, rather than the hazards of continued smoking, may be more effective (Riley et al.,
2017). Additionally, physicians promoting self-efficacy to make attainable future decisions is
beneficial, since many patients with lung cancer feel that they have not made good choices in the
past (Hamann et al., 2014; Riley et al., 2017). Particularly, physicians promotion of patient
autonomy (i.e. making decisions about smoking cessation) can bolster self-esteem and buffer
against stigma (Riley et al., 2017; van Eerd et al., 2015).
Overall, patients who smoke desire more empathy from physicians when discussing
smoking behaviors (Riley et al., 2017; van Eerd et al., 2015; Weiss et al., 2006). Physicians
report awareness of the sensitivity of this issue; one physician stated in a qualitative interview,
“You don’t want to compound any feelings of guilt or self-loathing by preaching at them about
their previous ‘evil ways’ ” (Wells et al., 2017, p. 8). Physicians may use empathic
communication to express openness to discussing patients’ emotional concerns during
conversations about smoking, which may provide a buffer for patients dealing with stigma
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(Morse et al., 2008; Weiss et al., 2006). Patients reported greater overall satisfaction (Bonito,
Horowitz, McCorkle, & Chagpar, 2013; Schofield et al., 2003), and reduced anxiety (Schofield
et al., 2003), when their physicians discussed emotional issues and shared reassuring statements.
Furthermore, patients’ perceptions of their physicians’ emotional supportiveness, but not their
technical skills, were associated with improved mental health (Mager & Andrykowski, 2002).
Overall, understanding and promoting effective communication skills when physicians navigate
conversations about smoking with patients with lung cancer is an important topic.
Significance
Although the importance of smoking cessation and the accompanying benefits has been a
topic of interest in the medical community for several years (i.e. Bell et al., 2012; Buchbinder et
al., 2014; Cataldo et al., 2010), an understanding of the content of conversations about smoking
is lacking, particularly with patients who are diagnosed with advanced lung cancer. This study
aims to understand the ways physicians navigate smoking conversations and provide a
comprehensive representation of the structure of and content within these conversations. The
large number of physician observations in this study provides a wealth of information regarding
the varying patterns of communication about smoking, generating a more complete picture of
how these conversations occur.
This study will add to our understanding of the communication patterns occurring
between the physician and the patient at their very first meeting, when the patient is likely
clarifying their diagnosis with the physician (Rutten, Arora, Bakos, Aziz, & Rowland, 2005;
Thorne et al., 2014). The initial consult between a patient and a physician can set the stage for
future meetings (Back, Arnold, Baile, Tulsky, & Fryer-Edwards, 2005), so this is a time when a
physician can set a precedent that they are sensitive to the stigma that patients with lung cancer
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often face. Many patients make behavioral changes, like smoking cessation, within the first few
months after a cancer diagnosis and desire discussion about these topics as they begin making
treatment decisions (Hsu, Kwan, Chawla, Mitina, & Christie, 2011; Kashigar et al., 2013).
Additionally, smoking cessation is more beneficial to prognostic survival and well-being the
earlier it is initiated (Gemine & Lewis, 2017; Nia et al., 2005).
To summarize, lung cancer is prevalent among older adults, and due to a large cohort of
baby boomers moving into older adulthood, rates are expected to increase in the next ten years to
the point that older adults will comprise 80% of the lung cancer population (Ayyappan,
Gonzalez, Yarlagadda, Zakharia, & Woodlock, 2011). Patients with lung cancer report that
disease stigma reduces quality of life (Brown Johnson et al., 2014; Cataldo et al., 2012),
increases anxiety and depressive symptoms (Cataldo & Brodsky, 2013; Gonzalez & Jacobsen,
2012), and is a barrier to seeking medical assistance (Tod et al., 2008; Tod & Joanne, 2010).
While smoking cessation provides health benefits, including improved prognosis (Berg et al.,
2013; Daniel et al., 2009; Parsons et al., 2010), it can also be a challenging topic due to stigma
surrounding smoking and lung cancer (Bell, Salmon, Bowers, Bell, & McCullough, 2010; Wells
et al., 2017). Physicians should consider the ways in which they navigate conversations about
smoking, particularly with patients with lung cancer, in order to minimize the negative effects of
stigma while still addressing the important health concern regarding smoking. A variety of
positive health effects may stem from positive communication about smoking including higher
rates of smoking cessation, treatment adherence, and better survival prognosis.
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CHAPTER 2: RESEARCH METHODS

This study uses qualitative content analysis to examine how physicians initiate and
navigate conversations about smoking with patients with lung cancer, including how physicians
provide support for smoking cessation or smoking-related stigma. This chapter includes the
primary study design (SBI), the dissertation study design, the qualitative theoretical perspective,
and the qualitative analytic strategy.
SBI Study Design
The data for this dissertation came from a larger study titled, “The Social and Behavioral
Influences Study” (SBI; Elias et al., 2017). Medical oncologists and primary care physicians
(PCPs) were recruited for this unannounced standardized patient study (N = 96). Using trained
patients, or medical actors, allowed for all physicians in our study to see a similar representation
of a patient with lung cancer. The SBI staff trained Standardized Patients (SPs) to portray a lung
cancer patient with similar health care records (i.e. stage 4 lung cancer), and smoking history, to
minimize bias that physicians may have toward different illnesses and their accompanying needs
(Zabar et al., 2014). Physical appearance and interpersonal communication styles were matched
when possible to reduce physician bias to differing patient characteristics as well (Zabar et al.,
2014). Using SPs minimized inter-patient effects that may be introduced when examining
communication with actual patients, effectively reducing extraneous patient characteristics that
may influence physician attitudes and behaviors (Srinivasan et al., 2006; Zabar et al., 2014).
Physicians were recruited from three states: New York, Indiana, and Michigan. Each
geographic region represented differing community types: New York included urban and
suburban sites, Indiana included rural locations, and Michigan included suburban sites.
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Physicians worked at university-based, community-based, or large healthcare systems. Eligibility
criteria required that physicians not be planning to leave their practice within a year, and
additionally for oncologists, eligibility criteria required that they treat patients with solid tumors.
Physicians were told that the purpose of the study was “to improve patient-physician
communication and clinical decisions by examining social and personal characteristics that can
affect clinical care and outcomes” (Elias et al., 2017). However, the primary aim of the SBI
study was to examine communication patterns between physicians and patients regarding pain
and pain medications associated with a lung cancer diagnosis. Therefore, standardized patients
were scripted to introduce discussion about their pain being intolerable and ask about refilling
prescriptions for pain medications.
At the time of recruitment, physicians completed a survey with demographic questions,
as well as multiple-item surveys assessing attitudes about medical topics (e.g., opioids, empathy,
employment satisfaction). Physicians were asked to complete a pain-based Implicit Association
Test a few weeks after they saw both SPs to assess implicit racial biases when assessing pain.
SPs completed 181 visits with 96 physicians. Physicians were primarily middle-aged
(mean=52.1), white (64%) and male (59%); 47% were oncologists, and 53% were PCPs (Table
1). After the physician completed appointments with both SPs, we provided them with a form
asking whether they thought they had seen an SP and asked for identifying data to confirm if
they were correct. 15% of physicians detected a visit as having an SP, with no differences
between oncologists and PCPs; the survey response rate was 97%.
The role of the SP was portrayed by a group of black and white men in each state, who
were trained to depict a 62-year-old with Stage IV lung cancer patient with bone metastases and
uncontrolled pain. The role specified that the SP was a divorced male who worked in the lumber
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department of a home improvement store in Georgia or Tennessee before moving in with their
adult child in New York, Indiana, or Michigan. The SPs medical record showed a history of
Stage IV lung cancer with bone metastases treated with radiation therapy and opioid medication
for pain. SPs report worsening chest and back pain as the main reason for their appointment.
Four roles were composed that differed by race and activation; otherwise the roles were identical.
The activated patients were trained to ask more questions and be more involved and
knowledgeable about their cancer. The typical patients had similar questions to ask the physician,
but were trained to discuss these questions only when prompted by the physician. Medical charts
indicated that all SPs had a long history of smoking a pack per day (approximately 40 years), but
had quit recently. SPs were trained to report this information in a similar manner, regardless of
activation, if a physician asked about their smoking history. Each SP received 50 hours of
training, including role-playing with the investigators to ensure credibility and reliability of their
portrayal of the role. Fidelity checks using the audio recordings were completed after each visit
and SPs were given feedback about their performance. Role fidelity was assessed using a
standardized scale; fidelity met 90% or higher criterion.
Physicians provided contact information for an employee who would assist with booking
appointments, covering issues with insurance, and providing physicians with electronic health
records delivered by the study. The contact was provided a realistic medical history record to
provide to the physician on the day of the SP visit. Research staff scheduled appointments for the
SPs with participating physicians by utilizing the administrative staff at each medical facility to
keep the appointment unknown to the participating physician. Each physician was scheduled to
see two SPs of the same race approximately four months apart; one SP displayed activated
behavior while the other SP displayed typical behavior. All conversations were recorded using
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concealed audio recorders carried by the patients. Each visit was covertly audio-recorded,
transcribed, and analyzed for content and process. After each appointment SBI staff collected
printed prescriptions and brochures provided to the SP, reviewed medical notes physician
entered during the appointment, and analyzed and rated audio-recordings to confirm SP fidelity.
Dissertation Study Design
This dissertation used a selection of transcribed audio recordings from the SBI study to
examine conversations about smoking during appointments with standardized patients with lung
cancer using qualitative content analysis. The final sample for this dissertation included 58
physicians who were primarily middle-aged (mean=54.2), white (52%) and male (64%); 47%
were oncologists and 53% were primary care physicians (Table 2). The selection criteria for this
study included cases where 1) the SP was not detected, 2) transcripts included a conversation
about smoking, and, 3) one transcript per physician was randomly selected from those denoted
with a conversation about smoking (Figure 1). Therefore, if a physician had more than one
transcript but only one included a conversation about smoking, that transcript was automatically
chosen for inclusion in this study.
Based on these selection criteria, 75% of the physicians from the main SBI study (that did
not detect the SP) asked about smoking in one of their recorded appointments. The average
length of an appointment was 33 minutes (range 8-84 minutes). The final sample of transcripts
for this study included appointments with 33 black standardized patients (57%) and 25 white
standardized patients (43%). Transcripts for this study included appointments with 27 activated
patients (47%) and 31 non-activated standardized patients (53%). Conventional content analysis
was used to examine the conversation as it occurred between the physician and the patient to
explore the following research questions:
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1. How and when do physicians initiate conversations about smoking?
2. How do physicians proceed through conversations about smoking?
3. How do physicians provide support for smoking cessation or smoking-related stigma?
Qualitative Research Design
Theoretical Perspective
“Traveler, there is no path. The path must be forged as you walk.” –Antonio Machado
The core tenants of a qualitative perspective include inductive exploration and discovery
with a strong consideration of the context-specific environment. Unlike quantitative
investigations, in which a researcher often takes a known path to investigate evidence to inform
an existing theory, in qualitative investigations researchers often take an uncharted path, and
therefore, must forge a path as they go. Qualitative research is often grounded in a constructivist
philosophical position, in which researchers argue that reality is constructed through multiple
contexts including social, cultural and historical conditions (Lindlof & Taylor, 2017; Tracy,
2012). The role of the researcher is to enter the world of the participant and examine how the
participant experiences, interprets, and understands the complexities of the situation or
phenomena of interest, and then provide a holistic overview of the meaning attributed to this
experience. Where quantitative methods focus on testing and verifying variables within a
phenomenon from an outside perspective, qualitative methods focus on exploring and
discovering the foundation of a phenomenon from the eyes of the research participant. Where
quantitative methods aim to “capture” and quantify existing data related to a specific
phenomenon, qualitative methods seek to explore variation and interpret the “essence” of a
phenomenon (Tracy, 2012). The purpose of qualitative research is to explore the “what”, or the
conceptualization of what a phenomenon is or is not, and the “how”, or the processes within that
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phenomenon. Qualitative research takes into consideration the environment surrounding the
phenomenon under investigation to produce findings that reflect a deep understanding and rich
description of the phenomenon of interest, including the real world context in which it exists
(Tracy, 2012).
Qualitative research embraces an inductive approach, where explorations of phenomena
are meant to generate and develop new ideas, and flexibility throughout the research process is
essential (Lindlof & Taylor, 2017; Tracy, 2012). Qualitative research is often designed to take
place in the natural context, allowing for events and experiences to naturally unfold, and the
researcher attempts to make sense and meaning of these phenomena as they occur. An essential
aspect of qualitative research is the understanding that work cannot be free of personal values
and perspectives (Lindlof & Taylor, 2017). Therefore, a key component is acknowledging the
researcher biases that might exist in the design, data collection, analysis, and reporting of a
study. Further, in qualitative research, the researcher is often the research instrument; data is
gathered directly from participants through conversations, observations, or artifacts, from which
the researcher as instrument analyzes and develops findings (Lindlof & Taylor, 2017). For this
particular study, there were a number of biases the lead researcher and coders acknowledged
throughout the process. First, the researchers expect that because the patient is diagnosed with
lung cancer, that smoking will be discussed in the majority of transcripts. Second, due to the
wide variation in physician demographics including gender, ethnicity, age, specialty, and
location, the researchers expect there will be a variety of communication behaviors occurring
throughout conversations about smoking. Third, because there is a lot of research illustrating
how patients with lung cancer report feelings to stigma, particularly with medical professionals,
the researchers expect there will be explicit linkages between smoking and the disease and
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possibly stigmatizing language about smoking and lung cancer. How these researcher biases
relate to the findings that emerged will be discussed in the concluding chapter.
While there are a variety of methodologies in qualitative research, this dissertation used
conventional content analysis to observe and analyze content collected, which in this case
includes conversations between physicians and standardized patients. This particular
methodology is advantageous with this data because it allows for the researcher to observe and
explore the interactions occurring between physicians and patients as they naturally unfold in a
more authentic context. This method allowed for insight into the conversational experience
regarding stigma and smoking that may be missed by a structured survey or randomized
experiment (Tracy, 2012). Rather than interviewing physicians and patients to explore their
opinions or perceptions regarding a particular phenomenon (i.e. stigma, smoking), this method
allowed for the researchers to observe the phenomenon in action. Rather than exploring how
participants “feel” about the phenomenon, researchers can observe “what” the phenomenon
entailed, and “how” the phenomenon is discussed or enacted (Tracy, 2012).
Qualitative Analytic Strategy
Conventional content analysis uses inductive strategies to generate interpretations from
text documents such as transcripts (Hsieh & Shannon, 2005). For this study, transcripts of
conversations between physicians and standardized patients were analyzed. Qualitative analysis
is an interactive and iterative process, where analysis is continually modified based on feedback
from the data (Sandelowski, 2010). The analytic process for this study progressed through four
steps: 1) review and organize data, 2) first cycle coding, 3) second cycle coding, and 4)
interpretation of findings (Table 3).
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Before analysis began, the research team reviewed the literature on smoking, lung cancer,
and stigma as a foundation for examining types of statements within smoking conversations.
While there was not a list of a priori codes for the researchers to use when coding, the review of
the literature and team discussion did provide a loose framework for what to observe in
conversation. Having a general understanding of smoking-related stigma, the researchers were
attentive to how physicians initiated conversations, particularly noting the context of the
conversation around that initiation of the topic. Researchers were also looking for ways to
categorize the types of statements physicians used within conversations about smoking, knowing
from the literature that physicians may provide praise, empathy, or a stigmatizing comment.
Additionally, researchers were observant of the process of conversation, particularly how
physicians responded in various ways to the similar statements about smoking that the
standardized patient was scripted to provide. Particular coding definitions and processes for each
research question are described alongside the findings.
Once a framework for analysis was established, the lead researcher reviewed the data to
determine if the research questions outlined would be suitable. When it was determined that a
majority of the transcripts included the topic of smoking, as outlined in the research questions, a
team of researchers began to sort transcripts for coding. All transcripts were examined to
determine if they included any reference to smoking and sorted into the appropriate category.
Coders looked for keywords in the text such as ‘smoke/smoker/smoking’, ‘tobacco’, ‘cigarette’,
‘pack’, or ‘drug’ and used context to determine if the statements were in reference to tobaccobased smoking. Each uninterrupted segment of conversation about smoking, including all back
and forth speaking turns by the physician and the patient, was highlighted for coding.
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Next, a team of four researchers engaged the data in first cycle coding, or open coding.
Open coding is the act of orienting to the data by engaging in initial coding (Saldana, 2015). The
research team immersed themselves in the data, examining each conversation to assign codes, or
a “word or short phrase that symbolically assigns a summative, salient, essence-capturing, and/or
evocative attribute” (Saldana, 2015, p. 3). Coding involves denoting researcher generated
constructs to pieces of data that give it meaning (Miles, Huberman, & Saldana, 2014). The
research team used a variety of coding methods: 1) descriptive coding, which assigns labels to
sections of data to create an inventory of topics, 2) process coding, which describes actions
occurring in the data, and 3) holistic coding, which examines the overall feel of a large chunk of
data (Miles et al., 2014; Saldana, 2015). Open coding continued as a cyclical process where the
researchers first orient themselves with a portion of the data to gather information, and after
organizing and recording initial codes, the team reviewed the process and refined or revised the
coding scheme. During this refining stage, codes were added, eliminated, or collapsed as
appropriate. This process was repeated until saturation was reached, meaning no new codes
emerged in the data (Miles et al., 2014; Saldana, 2015). The remaining data was divided among
the team, with all of the transcripts being double coded. Any discrepancies were brought to the
group for a coding decision.
During open coding, researchers independently examined smoking conversations within
transcripts line-by-line to categorize each speaker statement. Because this study utilizes
standardized patients, the statements by the patients were similar across all transcripts.
Therefore, coders focused on exploring physician initiated statements and physician response to
patient statements. While each individual statement in the conversation was coded, these
frequency counts were only used as a way to illuminate the overall patterns for the researchers.
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The findings are presented at the physician level, meaning that individual frequency counts for
each code are not reported. Rather a percentage of physicians that used any one category in their
conversation about smoking are reported. This first phase, open coding, revealed the most salient
and prominent categories of statements that occurred in smoking conversations (Table 4).
Once agreement was reached on all coding definitions and all transcripts were coded, two
researchers started the second phase, axial coding. Axial coding includes a secondary
examination of the data with the goal of investigating patterns and categories to develop
conceptual domains in the data (Saldana, 2015). For this study, two researchers developed
conceptual domains by examining comparisons among patterns both within and across
transcripts. First, researchers explored the properties of codes, how codes related to one another,
and assessed which codes were the most salient and representative of the data (Saldana, 2015). In
essence, in this stage of coding, the researcher refined, revised, and reduced the codes into
categories in order to “sharpen” the group of codes to have the best fit (Saldana, 2015), and to
illuminate patterns that help make sense of the data (Bowen, 2009). The following methods were
used during axial coding to construct categories from the data: 1) noticing patterns in codes, 2)
creating clusters of codes, 3) counting frequencies to understand consistency, and 4) comparing
and contrasting cases to assess variability (Miles et al., 2014). Once categories were generated
from the data, findings were described in rich detail with representative quotes pulled from the
data as appropriate. Finally, the findings were interpreted and synthesized to link them with the
literature and provide discussion points for future research.
Ensuring Qualitative Rigor
Qualitative rigor was ensured by meeting qualitative research standards set forth by Miles
et al., (2014): 1) objectivity, 2) reliability, 3) credibility, and 4) transferability. To ensure
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objectivity, the data was collected using a covert method (e.g. hidden audio recorder) to
eliminate a known observer in the room during the appointment. Using transcripts of
conversations provided an objective account of what occurred during each appointment that was
coded by multiple researchers. This ensured that researchers considered reflexivity, or the
researchers own bias, while coding and discussing transcripts as a team. Additionally, the
researchers documented the research process through detailed memos about coding and analysis.
To ensure reliability, the data used a large representative sample of physicians across multiple
states, specialties, and time points. Data procedures were articulated to ensure all locations
collected data similarly. Multiple researchers coded transcripts to verify coding consistency
across all data, and met regularly to ensure coding reliability. Finally, peer review with
appropriate reviewers acted as an external audit for the findings.
To ensure credibility, data that did not conform to the patterns generated for the majority
of the data were examined, and alternate explanations for findings were considered. Additionally,
the inclusion of multiple coders promoted discussion of alternate explanations. Rich descriptions
and examples from the data were included to establish authenticity. Researchers examined
precise details in the data during coding and analysis to ensure accurate and abundant
descriptions for each finding. To ensure transferability, a clear description of the sample and
context is provided, including any limitations based on sample or study design. Exploring the
similarities and differences among multiple cases builds a stronger rationale for generalizability
of findings beyond this study.
Summary
This study explores how physicians navigate conversations about smoking with
standardized patients with lung cancer. A subset of data was selected from the larger SBI study,
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which represents one randomly selected transcript that includes a conversation about smoking
from each physician that did not detect the SP. The research team examined the transcripts
selected for this study using qualitative content analysis in order to explore three research
questions: how physicians initiate conversations, how physicians proceed through conversations,
and how physicians provide support during conversations.
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CHAPTER 3: FINDINGS

Introduction
The purpose of this study was to examine conversations about smoking between
physicians and standardized patients presenting with lung cancer during an initial visit. By
assessing how physicians navigate conversations about smoking we gain a better understanding
of how these potentially sensitive conversations are structured, particularly regarding the
initiation, content, and provision of support within these conversations. This chapter presents key
findings obtained from qualitative analysis on 58 transcripts of conversations. Main findings are
reported in response to each research question.
The first research question examined how and when physicians initiated conversations
about smoking with patients with lung cancer. We found that the majority of physicians initiated
conversations about smoking either as part of the process of taking a medical history or during
conversations about the lung cancer diagnosis. The second research question examined how
physicians proceeded through conversations about smoking with patients with lung cancer. We
found that the content of conversations about smoking contained the following six main
categories: assesses smoking status, builds smoking history profile, praises smoking cessation,
connects smoking behaviors to diagnosis or treatment, provides empathy or understanding, and
presents a negative bias about smoking. The third research question examined how physicians
provided support for smoking cessation or smoking-related stigma. We found that physicians
communicated very little support regarding smoking cessation or smoking-related stigma. Even
though standardized patients provided similar opportunities for provision of support in a majority
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of the transcripts, less than a third of physicians responded with provision of support to these
statements.
The following is a discussion of each research question with an explanation of the coding
process and a detailed description that supports and explores each finding. Quotations from
transcripts are used to portray multiple perspectives and capture the richness and complexity of
this data. As the patient is portraying a standardized role, many quotations from their speaking
role are nearly identical across cases. Across all 58 transcripts included in this study,
conversations about smoking were typically short, with most transcripts containing six or fewer
statements by the physician about smoking. A majority of transcripts showed only one discussion
of smoking throughout the appointment, with only a handful showing two separate discussions
during the appointment; only one transcript contained three separate conversations about
smoking during the appointment.
Initiation of Smoking Conversation
The first research question explored how physicians initiate conversations about smoking
in an initial visit with a patient with lung cancer. To answer this question, coders indicated the
statement that initiated the conversation about smoking, and coded the statements occurring both
before and after this initiation statement to determine the overall context of the conversation.
Coders took a holistic perspective to examine what the topic of conversation was before the
smoking conversation was initiated, and then what the next topic of conversation was after the
conversation about smoking ended. Coders also made notes regarding who initiated the topic
first (physician or patient), and loosely assessed the timing of the initiation of the conversation
within the appointment by examining line numbers (beginning, middle, end). We found that 55
physicians in this study initiated a conversation about smoking during one of two time points in a
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conversation: while charting medical history (“charting;” 64%), or while discussing the lung
cancer diagnosis (“diagnosis;” 31%). Only three transcripts included instances where the patient
initiated the conversation about smoking rather than the physician.
Charting
Overall, the majority of conversations about smoking were initiated while the physician
was charting the patient’s medical history (n = 37, 64%). We defined initiation as charting when
smoking was discussed as a topic inserted between other questions about lifestyle behaviors such
as alcohol use, exercise habits, appetite, or sleep behaviors. These conversations typically
happened toward the beginning of the appointment, and often the physician would pause to type
the patient’s responses into the computer or have the patient fill out a form about their smoking
history. Physicians would generally use this as an opportunity to gain basic information about
their smoking behaviors rather than discuss smoking cessation or explain how smoking is related
to their disease. Physicians typically noted down the patient’s response, and moved to the next
question without addressing the patient’s responses more deeply. A typical conversation that
initiated smoking during charting would proceed similar to the following:
Physician: Are you allergic to anything?
Patient: No.
Physician: Do you smoke?
Patient: Not anymore. Let’s see. About six months ago I stopped.
Physician: Do you drink any alcohol?
Patient: Not much anymore.
Physician: Do you use any kind of street drugs?
[Physician 7]
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Diagnosis
Approximately one third of physicians initiated conversations about smoking during
discussions of the lung cancer diagnosis (n = 18, 31%). We defined initiation as diagnosis when
the conversation directly followed a reveal of the lung cancer diagnosis, either by the patient or
by the physician reading the medical chart. Typically these conversations were later in the
appointment after the physician had gathered a basic medical history and they were in the
process of confirming diagnosis and treatment options. Some of these conversations were more
directly tied to explaining how the patient’s lung cancer type is related to smoking. Using
smoking behaviors as a reason for the patient’s diagnosis, physician often cited evidence and
medical terminology from the medical record. In other cases, conversations about smoking were
embedded within discussion about next steps regarding the lung cancer diagnosis, such as
treatment options. Physicians would explain why particular treatment options were not available
for patients because of smoking history (i.e. Physician: “There is a treatment with pills. It’s not
for everybody, and it tends to be for people who are light smokers, which I’m guessing that’s not
you because you’ve been smoking for how many years would you say?” Physician 20). The
following is an example of a conversation where initiation of smoking occurred during a
diagnosis discussion:
Physician: What was the radiation for? You had a mass in your lung?
Patient: Lung cancer.
Physician: A smoker?
Patient: I was until six months ago.
Physician: Good for you. What about the lung tumor? It shrunk down?
[Physician 20]
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Additionally, there were some cases where the patient would share that they had lung
cancer, and a physician would use that as an opportunity to ask about smoking behaviors. This
was often closer to the beginning of the appointment when the patient was sharing their reason
for scheduling an appointment:
Patient: And that’s when I found out I had lung cancer.
Physician: Okay. Where you a smoker at all?
Patient: Oh yes, for quite a while.
Physician: Quite a while, okay. All right.
[Physician 2]
Patient Initiated
In a very few cases (n = 3, 5%), conversations about smoking were initiated by the
patient rather than the physician. We defined initiation by patient when the patient mentions
smoking before the physician did. At the start of some appointments, patients described their
smoking history while sharing the background of their diagnosis. This often occurred before the
physician had an opportunity to take their medical history or discuss their diagnosis and
treatment options. Two of our physicians took this as an opportunity to immediately continue
conversation about smoking by asking questions in response to the patient’s introduction of the
topic. The third physician waited until later in the process of filling out the patient’s medical
chart to bring up the topic again. The following is an example of a patient initiating a
conversation about smoking:
Patient: I had pain and coughing too. I knew that I did have a history, you know, I had
smoked cigarettes. But I stopped about six or so months before I started feeling worse.
Physician: Oh, how long were you smoking before that?
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Patient: 30 plus years.
Physician: Okay.
[Physician 8]
Navigation of Smoking Conversations
The second research question explored how physicians progressed through conversations
about smoking, particularly exploring the content of these conversations. To answer this research
question, coders labeled each statement within the conversation about smoking with a code.
Codes were refined, collapsed, and removed throughout the coding process. Researchers first
identified thirteen codes that encompassed the content of physician statements within smoking
conversations (Table 4). During the refinement process codes that were similar were condensed
into one category, codes that entirely overlapped with other codes were removed, and codes that
were not salient (occurred in less than 5 physicians) were removed. In one case, a code was
expanded into two categories to create clarification and distinction among physicians. For this
study, the thirteen original codes were condensed into six main content categories: assesses
smoking status (n = 55, 95%), builds smoking history profile (n = 30, 52%), praises smoking
cessation (n = 15, 26%), connects smoking behaviors to diagnosis or treatment (n = 11, 19%),
provides empathy or understanding (n = 7, 12%), and presents a negative bias about smoking (n
= 6, 10%). These content categories represent statements made by physicians in conversations,
but not all categories were present in all conversations; percentages represent the number of
physicians that had a statement within any given content category in relation to the sample used
for analysis (n = 58).
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Assesses Smoking Status
We found that the majority of physicians (n = 55, 95%) included an assessment of the
patient’s smoking status within the smoking conversation. In the three transcripts where the
patient initiated conversation about smoking, physicians did not need to assess smoking status
since the patient provided that information unprompted. We considered polar questions (i.e.
yes/no) about the patient’s current or former smoking status only as an assessment of smoking
status. These statements typically included one or two questions to determine if patients were
currently smoking or ever smoked. This was often the first statement a physician used in
smoking conversations. Examples of this include: “Do you smoke?” (i.e. Physician 7, 19, 48),
“Are you still smoking?” (i.e. Physician 1, 9, 46), or “Were you ever a smoker?” (i.e. Physician
2, 16, 30). Occasionally the physician would be confirming information provided in the medical
record about the patients current or former smoking status (i.e. “And this says you used to
smoking, but you quit?” Physician 31). Overall, statements were aimed to only assess current or
previous smoking status, not details of smoking behaviors.
Builds Smoking History Profile
A little over half of physicians (n = 30, 52%), continued smoking conversations with
questions that helped them build a detailed smoking history profile for the patient. We
categorized any physician’s questions or statements that inquired about the details of the patients
smoking habits as part of building a smoking history profile. The more commonly asked
questions included when the patient began smoking, how many years the patient smoked, how
many packs per day, and when the patient quit. Physicians sometimes used terms like “packyears” or “pack-per-day” to assess patient’s smoking quantity and length of time. Less
commonly asked questions included why the patient decided to quit, or if they had a family
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history of smoking. These questions were often asked one after the other while the physician
added patient responses into their medical chart. Questions were not always in the same order
across physicians, but the common questions usually appeared together in conversation. There
were no questions specifically aimed to ask about the use of other forms of tobacco such as
chewing tobacco, vape pens, or e-cigarettes. The following is an example of a conversation
where the physician builds a smoking history profile:
Physician: Yeah. How many years did you smoke for?
Patient: I would say probably forty.
Physician: Forty? Okay. How much were you smoking? A pack a day or two?
Patient: A pack a day.
Physician: Okay. And you quit in March, right?
Patient: About six months ago.
Physician: Six months ago, so it would have been what, September or October,
something like that?
[Physician 40]
Praises Smoking Cessation
Approximately a quarter of physicians (n = 15, 26%) included praise for smoking
cessation. We included statements that provided positive reinforcement for the patients’ choice
to quit smoking. Statements of praise typically followed a patient’s report about smoking
cessation and were often focused on scientifically based benefits of smoking cessation,
particularly for patients with lung cancer. The majority of physicians who provided praise for
smoking cessation, did so immediately after the patient reported quitting. Very few physicians
reiterated praise later in the conversation. However, one physician praised the patient multiple
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times for smoking cessation, often in the middle of conversation about unrelated topics (i.e.
Physician: “When you go home, have your daughter call Dr. [name]. He is very good, he is part
of my team. Yeah. And I’m glad you quit smoking.” Physician 3). While most statements were
explicitly categorized as praise, there were a few that were too vague to define and therefore not
included (i.e. “Okay Good” Physician 45). The more explicit praises were not very long,
typically only one or two sentences within the conversation about smoking (i.e. “Well that’s very
good. No joke, that’s very important” Physician 26). Following is an example of praise for
smoking cessation that included a description of the benefits of cessation:
Physician: Do you smoke?
Patient: Not anymore. I stopped.
Physician: When did you quit?
Patient: It’s been about six months.
Physician: Okay. Good for you…We still think it’s beneficial no matter what, even after
you get the cancer diagnosis. Studies have shown that people that actually quit smoking,
they tolerate treatment better. They feel better and maybe even live a little bit longer.
[Physician 19]
Connects smoking behaviors to diagnosis or treatment
Approximately one fifth of our physicians included statements that connected prior
smoking behaviors to diagnosis or treatment options (n = 11, 19%). We included any statement
that linked smoking to any aspect of explaining the diagnosis or discussing treatment options
under this code. These statements were not explicitly positive or negative, but rather neutral factbased statements regarding the type of lung cancer and its known association with smoking
behaviors. These statements often included medical terminology regarding the specific name for
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the cancer the patient had, along with the statistics regarding its association with smoking (i.e.
“One out of four people who smoke get lung cancer. That’s a pretty high statistic” Physician 29).
While most physicians implied they were very certain that the diagnosis was due to smoking
behaviors, one physician shared that the patient had a history that included multiple risk factors
apart from smoking such as dust inhalation at the patient’s work. Some physicians paired these
statements with an empathic statement to acknowledge potentially difficult emotions as a patient
comes to understand that their behaviors may be related to this diagnosis. The following is an
example of a conversation where the physician connects smoking to the patient’s diagnosis:
Physician: This is commonly seen in patients who have a history of smoking.
Patient: Oh.
Physician: If I have to say what really caused it, this was your years of smoking that
probably caused your squamous cell cancer.
Patient: Right.
Physician: The next question that is in your mind is where is it, right?
[Physician 24]
Less often used were statements that stated how smoking behaviors might influence
treatment options available. These statements often included medical terminology to describe
how the type of lung cancer that is related to smoking is or is not responsive to particular
treatment options (i.e. “There are also some pills available, but again, unfortunately you may not
be a candidate because you are a smoker” Physician 47).
Provides empathy or understanding
Very few physicians provided statements of empathy or understanding (n = 7, 12%). We
defined this code as statements that made an attempt to connect with the patient in a personal
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way, provided empathy about the patient’s current situation, or acknowledged the patient’s
feelings. Statements of empathy or understanding were often included when a patient described
the challenges of smoking cessation. These statements often reflected that the physician
understood the difficulties associated with withdrawing from nicotine or a comforting habit,
particularly during the stress of a cancer diagnosis. One physician provided empathy through
sharing his own struggles with smoking cessation (i.e. Physician: “I quit a couple times. Then
went back.” Physician 17). Empathy was also sometimes included along with a discussion about
the relationship between smoking and a lung cancer diagnosis. These statements often reflected
that the physician understood the emotional burden of learning that the lung cancer diagnosis is
highly associated with prior smoking behaviors, and further that this may impact future treatment
options (i.e. Physician: “Lung cancer is one of the most devastating things, which is related to
years of smoking sometimes. Not everybody gets it” Physician 39). While most statements coded
in this category were explicitly empathic, others were vague (i.e. “I understand” Physician 4),
and therefore not included in this analysis. Following is an example of a physician providing
empathy in relation to the patient’s potential frustration at being diagnosed after actively making
the choice to quit smoking:
Physician: And you don’t smoke anymore, right?
Patient: No.
Physician: When did you give that up?
Patient: About six months ago.
Physician: Okay. It figures, right? And then you get diagnosed with cancer…Oh dear.
Well, at least you quit. It’s behind you, so that’s the good thing.
[Physician 14]
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Presents a negative bias regarding smoking
Very few physicians made statements in their conversations about smoking that reflected
a negative bias about smoking behaviors or patients who have smoked (n = 6, 10%). We coded
statements that appeared to share a negative personal opinion regarding smoking behaviors or
those who have smoked under this category. These were statements that alluded to negative
perceptions or stereotypes about people who smoke, such as their physical appearance (i.e. “You
don’t look like a smoker anymore. You know, you got some good color” Physician 28), personal
characteristics (i.e. “Being a smoker, you have some addiction tendencies” Physician 35) or
suggesting smoking being a “deviant” behavior choice when initiating the topic of smoking (i.e.
“Do you drink or do anything you shouldn’t be doing?” Physician 29). Additionally, some
physicians shared statements that discounted patient’s previous attempts to quit smoking, which
may have reflected personal opinions about patients who find smoking cessation to be a
challenge (i.e. “That doesn’t count. We don’t count those [chuckles]. Okay, because if it’s quitquit and it’s cold turkey you don’t ever go back to it.” Physician 41). Overall, there were very
few statements that presented a negative leaning bias about smoking or those who smoke, and
they were not overtly stigmatizing or communicating a widely held stigmatizing view.
Provision of Support in Conversations
The third research question explored how physicians communicated provision of support
to patients. For this research question, we were particularly interested in how support may be
provided in a unique context of being diagnosed with a disease in which prior lifestyle behaviors
may be related. First, we revisited our transcripts to examine how physicians provided support in
order to create an understanding of what conditions and contexts encouraged physician provision
of support in our data. Based on our examination we found that there were no medical supports
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offered to our patients, such as medication or tips for continued smoking cessation. Although our
patients report having quit within the past six months, none of our physicians discussed the risk
of relapse or the patient’s plan for continued smoking cessation in the future. We found no
mention of patches, pills, gum or other prescription or over-the-counter support for continued
smoking cessation. We also did not find any discussion of supports for mental health issues, such
as anxiety or depression, related to smoking-related stigma.
However, we did find that some physicians might have been attempting to provide
emotional support, mostly by way of provision of praise or empathic comments. We found that
opportunities for praise or empathy generally came up in two contexts: 1) when patients shared
that they chose to quit smoking, and 2) when the physician explained the connection between
smoking behaviors and the disease and/or treatment options. During conversations about
smoking cessation, physicians typically provided support through communicating that they
approved of the patient’s behaviors with positive reinforcement statements such as “Good
thinking” (Physician 1) or “That is fantastic” (Physician 30). Additionally, during conversations
about smoking cessation, physicians provided support by showing an understanding for the
challenges of facing nicotine addiction by using empathic statements such as “It’s hard isn’t it”
(Physician 11). During conversations about the diagnosis or treatment options, physicians used
statements possibly intended to show an understanding of the difficulty of learning that the
disease is linked to the prior smoking behaviors, such as “It’s hard, I have seen my patients go
through this” (Physician 39).
To explore this further, we revisited transcripts that included the codes “praise” or
“empathy” to examine what the patient or physician said before the statement of praise or
empathy. We considered these preceding statements as provided opportunities for emotional
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support. Using this definition of “provided opportunity”, we then revisited the remaining
transcripts that did not include the codes “praise” or “empathy” to examine if the transcript
included opportunities for praise or empathy that went unacknowledged. This analysis
encompassed 18 transcripts that included physician response to patient provided opportunities
for praise or empathy (“acknowledged opportunity”; 31%), and 35 transcripts that did not
include physician response to opportunities for praise or empathy (“unacknowledged
opportunity”; 60%). In the small group of transcripts that had no opportunities for praise or
empathy (5), the conversations were simply too short to incite provision of praise or empathy,
and therefore were excluded from analysis. In these conversations, the physician typically
phrased conversation about smoking as a rhetorical question, which did not allow for space for
much of a patient response beyond a yes or no answer (i.e. “I noticed it said you smoked for a
while, are you having any trouble with shortness of breath?” Physician 38). After excluding these
transcripts, we compared the acknowledged opportunity group with the unacknowledged
opportunity group to explore in what ways the conversations were similar or different to gain a
further understanding of how physicians navigate sensitive topics. As a result of using
standardized patients, statements by the patients were relatively similar across all transcripts
allowing for a stable comparison between groups. The following section describes, for each of
the two contexts, how conversations differed between the two groups including comparative
examples from the transcripts.
Smoking status and challenges with cessation
The manner in which physicians broached the topic of smoking was similar across the
groups, with most physicians using a similar statement to inquire about smoking status.
However, one difference between groups for a few physicians was language that suggested an
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understanding that smoking cessation is a challenge that may not have been attempted yet (i.e.
“Are you trying to cut down at this point?” Physician 45), compared with language that may
suggest the patient should have quit already (i.e. “Are you still smoking or what?” Physician 50),
or a nonverbal response to the patient reporting having recently quit (i.e. Physician: “Did you
smoke?” Patient: “I did, yes. Up until six months ago.” Physician: “Ay yay yay.” Physician 28).
Additionally, physicians in the unacknowledged opportunities group used more language that
limited the patient to a “yes” or “no” response about their current or past smoking behaviors (i.e.
Physician: “And you quit smoking in 2012.” Patient: “Yes.” Physician: “Are you moving your
bowels?” Physician 23), rather than open-ended questions with additional questions to prompt
further discussion (i.e. “Physician: To get a better sense of what your lifestyle has been like, have
you ever been a smoker?” Patient: “Yes.” Physician: “A-huh. Tell me about that.” Physician 30).
Therefore, in the transcripts for the unacknowledged opportunity group, patients were less likely
to expand upon their smoking history, including personal challenges with smoking cessation,
reducing opportunity for praise or empathy.
Patients shared that they recently quit smoking in a similar way and at a consistent rate in
both groups. While patients in the acknowledged opportunity group were mostly met with praise
immediately following this statement (i.e. Physician: “When was the last time you had any
cigarettes?” Patient: “Six months ago.” Physician: “Congratulations. That is fantastic.” Physician
30), those in the unacknowledged opportunity group were not given praise. In the
unacknowledged opportunity group physicians typically replied with a basic affirmation that
they heard the patient (i.e. “Ah”, “Okay”, or “Got it.”) rather than praise, and moved directly to
the next topic (i.e. Physician: Were you ever a smoker? Patient: I was a smoker…I quit about six
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months ago. Physician: Okay. So, I heard it was all of a sudden you developed a cough, trouble
breathing? Physician 16).
While discussion regarding the challenges of smoking cessation may have occurred less
frequently in the unacknowledged opportunity group, there were patients in both groups that
shared personal challenges regarding smoking cessation, including that they had tried to quit
multiple times in the past. In the acknowledged opportunity group, physicians shared an
understanding of the challenge of smoking cessation, with one physician sharing their own
personal history of smoking and smoking cessation. Physicians often used empathic statements
to show understanding of the difficulties patients face when trying to quit (i.e. Patient: “I stopped
totally around six months ago. And I tried to stop over the years. And I would stop sometimes.”
Physician: “It’s hard, isn’t it?” Physician 11). However, in the unacknowledged opportunity
group, physicians typically provided affirmation that they heard the patient, but moved directly
to asking a new question rather than providing empathy or understanding (i.e. Patient: “I quit
about six months ago, finally. I tried a couple of other times before that unsuccessfully. But you
know, I just started not feeling well and I thought I’ve got to stop this. I finally just quit and
never looked back. I’m so glad.” Physician: “And you’re working now?” Physician 6). Some
physicians even shared a negative response such as discounting the patients past attempts to quit
(i.e. Physician: “That doesn’t count. We don’t count those [chuckles].” Physician 41).
Connections between smoking behaviors and disease and/or treatment
Additionally, physicians in both groups discussed the connection between smoking and
the diagnosis or treatment options at a similar rate. While physicians in the acknowledged
opportunity group included empathic language regarding the difficulty of learning that the
diagnosis is linked to past behaviors that patients may not have known were hazardous (i.e.
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Patient: “Actually I quit [smoking] about six months ago. The irony is after I quit, then I started
feeling bad.” Physician: “Feeling sick. Yea, that does happen. It was brewing and you didn’t
know it. And you sure didn’t sign up for this.” Physician 46), those in the unacknowledged
opportunities group used statements that focused on the scientific diagnosis using medical
terminology (i.e. “Now I have the biopsy report, which is consistent with what we call squamous
cell carcinoma, which is typically seen in patients that are smokers. So, your cancer was created
by smoking. We know that.” Physician 43). While physicians in the unacknowledged group
focused on the scientific facts that link smoking behaviors with lung cancer, those in the
acknowledged opportunity group were more likely to use emotive language and statements that
recognize the human response to this news (i.e. Physician: “Lung cancer is one of the most
devastating things, which is related to your years of smoking sometimes. Not everybody gets it. I
have seen my patients go through this, it’s hard.” Physician 39; Physician: “This was from
smoking, so it will not be passed on to your kids. Just so you’re not worried about that.”
Physician 17).
Overall, there were very few conversations regarding how smoking behaviors influence
future treatment options. None of the physicians in the acknowledged opportunity discussed
specific treatment options with relation to the patients past smoking behaviors. Rather they
focused on the scientific benefits of smoking cessation for future health, typically included
alongside their praise for the patient having recently quit smoking (i.e. Physician: “It was a good
time [to quit smoking]. Despite the fact that the cancer is already there, stopping does make
people do better with infections and so forth.” Physician 22). Physicians in the unacknowledged
opportunity group were more direct in their discussion of how smoking may influence future
treatment options; often using medical terminology about the particular cancer the patient has
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and how it relates to the treatments available (i.e. Physician: “There are also some pills available,
but again, unfortunately you may not be a candidate because if you are a smoker, it is locked into
your tissue. So, we looked at the actual mutation in your tumor, and you’re not a candidate for
the pill.” Physician 47). Additionally, one physician used potentially stigmatizing language
during a conversation about which opioid they may prescribe to deal with pain to indicate that
their personal opinion regarding personality traits of those who have smoked (i.e. Physician:
“Being a smoker means you have some addictive tendencies.” Physician 35), may influence their
decision about which medication to prescribe.
Summary
This chapter identified findings with regards to three research questions about how
physicians navigate conversations about smoking with patients with lung cancer. Our first
research question was about the initiation of conversations about smoking, and we found that the
majority of physicians initiated conversations while taking a medical history or during
conversations about the lung cancer diagnosis. Our second research question was about what
physicians say during conversations about smoking, and we found that six primary categories
encompassed the content of conversations: assesses smoking status, builds smoking history
profile, praises smoking cessation, connects smoking behaviors to diagnosis or treatment,
provides empathy or understanding, and presents a negative bias regarding smoking. Our third
research question was about how physicians provide support, and we found that while physicians
do not provide medically-based support for smoking cessation or smoking-related stigma,
approximately one third of physicians attempt to communicate emotional support. This study
provided an exploratory look into how physicians initiate and navigate conversations about a
sensitive topic, such as smoking, with older male patients with lung cancer. Overall, the
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physicians in this study shared many similar patterns of conversation when discussing smoking
behaviors, and we highlighted the unique approaches used by different physicians. The next
chapter discusses the connections between findings from this study and the larger body of
literature regarding lung cancer and stigma.
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CHAPTER 4: DISCUSSION

Lung cancer, the second most commonly diagnosed cancer, is a leading cause of death
among older adults (Cronin et al., 2018; Siegel et al., 2017). There are numerous health benefits
associated with smoking cessation in patients with advanced lung cancer (Gemine & Lewis,
2017; Parsons et al., 2010), yet up to 30-50% of patients with cancer continue smoking after a
diagnosis (Cooley et al., 2009; Guimond et al., 2017). As physicians are aware of the perceived
stigma associated with smoking and lung cancer, many choose to avoid length conversations
about smoking to protect patient’s from feelings of shame and guilt that may arise (Champassak
et al., 2014; Wells et al., 2017). Therefore, conversations about smoking cessation are infrequent
and often lack physician support for cessation (Warren, Marshall, et al., 2013; Wells et al.,
2017). However, given that patient’s are more successful with smoking cessation when they have
physician support (Stead et al., 2013), it is important to understand how physicians can have
conversations about smoking in a way that is tailored to patients with lung cancer and possibly
smoking-related stigma. Thus, this study explored how physicians navigated conversations about
smoking with patients with lung cancer, to establish groundwork for communication behaviors
that are present, and provide suggestions for communication behaviors that may be lacking. In
the following chapter a summary of key findings, and an interpretation of these findings will be
presented. Additionally, the implications, future directions, strengths, and limitations of this
study will be addressed.
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Summary of Key Findings
This study examined how physicians navigate conversations about smoking with patients
with lung cancer. Our findings explore the context surrounding conversations, the content within
conversations, and provision of support through conversations. Our first research question
examined the context of the conversation surrounding conversations about smoking, including
who initiated the conversation, when the conversation occurred within the appointment, and how
the conversation was initiated. We found that the majority of conversations about smoking were
included within two contexts; either as part of the process of taking a medical history or during
conversations about the lung cancer diagnosis. Our second research question examined the
content within conversations about smoking; specifically what types of statements were used
within conversations. We found that the content of conversations about smoking contained the
following six main categories: assesses smoking status, builds smoking history profile, praises
smoking cessation, connects smoking behaviors to diagnosis or treatment, provides empathy or
understanding, and presents a negative bias about smoking. Our third research question
examined physician provision of support during conversations about smoking. We found that
even though standardized patients provided similar opportunities for provision of support in a
majority of the transcripts, less than a third of physicians responded with provision of support to
these statements. Overall, this study highlights that while a majority of physicians ask patients
about smoking, most physicians aimed for these conversations to be short, routine, and medically
driven. Therefore, conversations about smoking were not tailored to meet the specific needs of
patients with lung cancer, which might include additional provision of support for smoking
cessation and recognition of smoking-related stigma. Physicians missed opportunities to make
subtle changes that could make an impact on patient well-being, such as asking patients if they
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needed support with continued cessation, praising patients for smoking cessation, or providing
empathy when discussing how the diagnosis was related to smoking behaviors.
Interpretation of Findings
An interpretation of the findings is presented that explores the meanings and relationships
that cut across the key findings from all three research questions. To interpret the findings, the
lead researcher explored patterns that illuminated how findings were interconnected, similarities
and differences among findings, and considered multiple explanations for findings. Through this
exploration of the findings, five major themes emerged that comprise the interpretation of the
findings. Overall, conversations about smoking: 1) were primarily physician-driven, 2) were
short and similar across cases, 3) emphasized medical topics, 4) emphasized gaining information,
and 5) were not tailored to lung cancer. The themes represent a holistic and synthesized view of
how the findings from each research question are interconnected and additionally, how they are
related to a broader context of physician-patient communication and related literature.
Conversations about smoking were primarily physician-driven.
The majority of physicians in our study (75%) asked about smoking behaviors in a first
appointment with a patient with lung cancer. This aligns with prior research that indicates that
while both physicians and patients find conversations about smoking to be challenging (Warren,
Marshall, et al., 2013; Wells et al., 2017), it is something that many physicians feel is an
important part of lung cancer management (Warren, Marshall, et al., 2013). Additionally,
physicians initiated conversations about smoking in a large majority of our transcripts, despite
literature indicating that some physicians wait for patients to initiate these conversations (Bell et
al., 2012). Physicians willing to initiate conversations about smoking may be important when
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working with patients with lung cancer who may not openly share their smoking status or have
delayed seeking healthcare because of their former smoking behaviors (Smith et al., 2008; Stuber
& Galea, 2009). In the three transcripts in which patients initiated the conversation about
smoking, the physicians chose to follow-up with additional questions. Overall, the fact that the
majority of physicians initiated questions about smoking indicates that physicians are not only
willing to ask about smoking behaviors, but likely have predetermined plans to ask patients
about smoking. Considering that approximately 30-50% of patients continue to smoke after a
cancer diagnosis (Cooley et al., 2009; Guimond et al., 2017), and that medical records can have
outdated or incorrect information regarding patient’s smoking history (Cole, Pflugeisen,
Schwartz, & Miller, 2018; Kats, Thornton, Kaelber, & Tarabichi, 2018), it is valuable for
physicians to initiate conversations about smoking.
While physicians may be willing to ask about smoking behaviors, they appear less
inclined to have longer discussions about smoking beyond the patient’s medical history.
Physicians appeared to command the direction and length of conversations about smoking.
Physicians structured conversations to encourage short responses, often by discussing smoking
during the process of recording their medical history in which patients were encouraged to
answer questions succinctly as they are asked in quick succession on a list. Physicians also
typically opted for questions with a distinctly short answer response (i.e. yes/no, year, number of
packs) rather than open-ended questions (i.e. “Tell me more about that”). However, open-ended
questions may be more effective when discussing smoking cessation with patients (Codern-Bové
et al., 2014). When patients provided more information than requested, physicians typically did
not engage in furthering the conversation about this new information, opting to provide simple
affirmation (i.e. “Okay”, or “Mm-Hmm”) before moving the conversation in another direction.
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Taken together, these patterns indicate that while physicians are willing to ask about smoking,
they maintain some level of control over the length and depth of these conversations.
Conversations about smoking were short and similar across cases.
Overall, conversations about smoking were more of an interaction rather than a
discussion. The majority of conversations were relatively short, typically only assessing smoking
status and at times asking additional questions about the patient’s smoking history. Only a
quarter of conversations included any additional content. Therefore, smoking was more of a
topic to be covered than an in-depth conversation. Additionally, we found that even when
looking across locations, genders, and specialties, conversations about smoking had little
variance. The majority of conversations progressed in a similar manner, with many phrases being
used almost verbatim across transcripts. The majority of physicians discussed smoking only one
time in an appointment, and these conversations were relatively short. Physicians initiated
conversations and discussed content within these conversations using very similar language. The
results of our coding indicated that only a few categories were salient among physicians. Overall,
the content within conversations about smoking could be mostly described with six categories:
assesses smoking status, builds smoking history profile, praises smoking cessation, connects
smoking behaviors to diagnosis or treatment, provides empathy or understanding, and presents a
negative bias about smoking. These findings offer insight into a rarely examined aspect of lung
cancer communication: the structure and processes of conversations about smoking.
While there is no current literature using observations of physicians and patients with
lung cancer having conversations about smoking, these findings may connect to qualitative work
exploring how physicians report navigating conversations about smoking. We found that
conversations were relatively short, which could be an indicator that physicians feel they do not
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have enough time in appointments to cover every topic adequately (Champassak et al., 2014;
McIlfatrick et al., 2013). The first appointment with a new patient with cancer can require
dedicated time for discussing the details of the diagnosis, treatment options, adjusting
medications, and making appointments with other specialists (Tai-Seale, McGuire, & Zhang,
2007), leaving little opportunity for physicians to address every topic in detail. Our findings also
align with research, in which some physicians report that they intentionally only ask patients one
or two questions about smoking during charting, to allow patients the opportunity to decide
whether or not they wanted to pursue further conversation about the topic (Wells et al., 2017).
Additionally, we found that conversations lacked variability, which may indicate that
some physicians may feel unprepared or untrained to deviate from basic medical questions
regarding smoking. It is possible that physicians that do feel it is important to broach the topic of
smoking, feel that they lack training to discuss smoking cessation or provide coping strategies to
patients (Warren, Marshall, et al., 2013; Wells et al., 2017). However, the lack of variability in
conversations about smoking may be due to the fact that physicians saw a similar stimulus, the
standardized patient, who used similar scripted responses about smoking behaviors. Overall,
these patterns indicate that conversations about smoking were relatively short and similar despite
variability in physician sample, and the literature indicates there may be a multitude of reasons
for why conversations about smoking tend to be short and similar.
Conversations about smoking emphasized medical topics
Conversations about smoking were often focused on medical topics, with relatively no
discussion of emotional issues, such as guilt or shame, in relation to smoking cessation or
smoking-related stigma. Half of the content codes about smoking were related to the medical
necessity of knowing smoking history and how smoking history might influence patient’s disease
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or treatment. For example, physicians’ questions were primarily focused on understanding
patients smoking history, or giving informative statements about how smoking is related to the
disease or diagnosis. Physicians rarely discussed the patient’s emotions regarding smoking and
lung cancer, particularly regarding feelings of guilt that may arise due to smoking-related stigma.
Medical terminology was often used to describe how smoking behaviors were linked to the lung
cancer type or ability to partake in particular treatments (i.e. squamous cell cancer, gene
mutation), whereas, very few physicians used emotive language that relate to the human aspect
of a cancer diagnosis (i.e. devastating, worry). This finding aligns with previous research that
indicates physicians, particularly oncologists, feel discomfort with addressing negative emotions
(Morgan et al., 2010), and therefore choose to stay with medical discussion when possible.
These findings highlight an important aspect of the physician-patient relationship that may be
overlooked by physicians: discussion emotions related to smoking cessation or smoking-related
stigma, particularly with patients with lung cancer. Current literature suggests that physicians
report being unprepared to discuss emotional issues (Chapple et al., 2004), and therefore have
concerns that these conversations may negatively impact their relationship with patients
(Champassak et al., 2014; Wells et al., 2017). However, patients report higher physician
satisfaction in relation to physicians emotional support, not technical skills (Bonito et al., 2013;
Mager & Andrykowski, 2002), and report health benefits such as reduced anxiety and resilience
to stigma when physicians address emotional concerns (Schofield et al., 2003; Shen et al., 2016).
In our data, we had two codes that were related to providing support to the patient by way of
praise or empathy. We coded emotional support in only a third of physicians. Even when the
patient provided an opportunity for physician praise or empathy, or the conversation allowed for
an opportunity for these supports, a majority of physicians opted to direct conversation toward
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medical issues instead. However, Farley et al., (2016), found that patients with lung cancer report
using smoking as a way to deal with psychological distress associated with the cancer diagnosis.
For this reason, it may be more important for physicians to address emotional issues with
patients as the alternative may include continued smoking. Overall, physicians spent the majority
of time during conversations about smoking discussing medical topics rather than the emotions
that may be related to smoking cessation or smoking-related stigma, and therefore very few
physicians provided support for emotional concerns.
Conversations about smoking emphasized gathering information
Conversations about smoking appeared to have the goal of gathering information, rather
than providing tangible support. While conversations about smoking were generally focused on
medical topics, one medical topic was noticeably absent: continued smoking cessation. The
patients in our study reported having quit smoking within the past six months, which would put
them at risk of relapse according to literature that indicates that half of all patients with lung
cancer that attempt smoking cessation relapse (Cooley et al., 2009; Walker et al., 2006), and
relapse risk continues even up to one year after quitting (Guimond et al., 2017). Despite the risk
of relapse and the reported hazards of continued smoking (i.e. Berg et al., 2013; Daniel et al.,
2009; Parsons et al., 2010; Warren, Kasza, et al., 2013), no physicians in our study provided any
tangible support for continued smoking cessation. There were no discussions about medications
to support cessation (over-the-counter or prescribed), support groups for patients with lung
cancer, or effective tips for smoking cessation. A few physicians provided informative
statements on the medical benefits of continued cessation with regards to reduced pain levels,
fewer infections, and increased life span, all of which reflected current literature (Cataldo et al.,
2010; Gemine & Lewis, 2017; Parsons et al., 2010).
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Our findings are consistent with other studies in which patients report a lack of support
from physicians, and inadequate discussion of smoking cessation, as barriers to continued
cessation (Wells et al., 2017), and few receive prescriptions for smoking cessation medications
or suggestions to seek out over-the-counter medications (Cooley et al., 2009; Schnoll et al.,
2004). Similar to others, we found that while many physicians discuss smoking more generally
during appointments, very few physicians provide tangible smoking cessation supports (Farley et
al., 2017; Warren, Kasza, et al., 2013; Wells et al., 2017). Our findings may expand upon our
current understanding of why physicians rarely discuss smoking cessation. While patients with
lung cancer want physicians to initiate conversations about smoking cessation (Farley et al.,
2016), physicians report that they intentionally only ask about smoking as part of the lifestyle
behavior questionnaire to allow patients the opportunity to indicate their willingness to discuss
smoking cessation (Wells et al., 2017). Some literature suggests physicians worry discussion
about smoking cessation may signal “preaching” or “policing” of patient behaviors (Champassak
et al., 2014; Wells et al., 2017), but patients actually rank physicians who discuss smoking
cessation more positively on patient satisfaction measures (Winpenny et al., 2017). Additionally,
literature suggests that physicians may have a negative bias about the ability of patients who
have smoked to adhere to treatment plans (Warren, Marshall, et al., 2013; Wassenaar et al.,
2007). However, (Stead et al., 2013), found that physician need not dedicate the whole
appointment to smoking cessation; even a brief discussion of cessation (e.g. less than 20
minutes) and one follow-up visit from physicians was beneficial in cessation rates up to one year
later. Overall, our findings indicate that physicians used conversations about smoking as an
opportunity to gain information about past smoking behaviors rather than an opportunity to
provide support for future continued cessation. It is possible that physicians felt since our
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patients reported having quit smoking that continued conversation about cessation was
unnecessary, but literature on smoking relapse would suggest conversations about smoking
cessation are valuable for patients who are still newly abstinent.
Conversations about smoking were not linked to lung cancer
Based on examination of our transcripts, it appeared that physicians did not structure or
style conversations about smoking in a particular way based upon the patient having a lung
cancer diagnosis. Smoking was not discussed in 25% of our cases, indicating that being
diagnosed with lung cancer does not inevitably invite a conversation about smoking. Further, in
cases where smoking was discussed, almost two-thirds of conversations (64%) occurred before
any discussion of the lung cancer diagnosis, often during the process of charting the patient’s
medical history. The physician may have looked at the chart before the appointment to know that
the patient had lung cancer, but in many cases it was apparent that the physician learned about
the diagnosis as conversation progressed through during the appointment. Some physicians
admitted to not having time to look at the chart, and asked the patient why they were coming in
for an appointment, and often this occurred after the initial medical history process, where a
majority of our physicians asked about smoking. This finding is surprising, given that up to 90%
of patients diagnosed with lung cancer smoked at some point in their life (Park et al., 2012), and
smoking is widely associated with a lung cancer diagnosis (Brown Johnson et al., 2014; Cataldo
et al., 2012).
In our study, questions about smoking history were often embedded between other
lifestyle questions (i.e. sleep habits, appetite, alcohol use) that are not necessarily specific to a
lung cancer diagnosis. Additionally, physicians appeared to have a goal of obtaining smoking
history information, not conversing to make goals or behavior change plans with regard to
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smoking, which indicates that smoking is part of a lifestyle behavior checklist that is likely asked
of every patient. This is in line with literature that suggests physicians deliberately discuss
smoking during the charting process so that it appears to be something they ask of every patient
and not a topic initiated because they have lung cancer (Wells et al., 2017). Approximately onethird of our physicians explicitly linked conversations about smoking with the lung cancer
diagnosis, and possible treatment options available because of smoking history. These
conversations suggest that some physicians may have navigated this topic in a way that was
more meticulously linked to lung cancer. However, our findings suggest that for a large majority
of physicians in our study, they chose to navigate conversations about smoking in a way that
may be similar for all patients regardless of disease type. Given that patients with lung cancer
report smoking as a stigmatizing subject (Tod & Joanne, 2010), and given that patients with lung
cancer report higher rates of mental distress and stigma than other cancers (Carter-Harris et al.,
2014; Lebel et al., 2013; Vodermaier et al., 2011), it may be particularly important for physicians
to tailor conversations about smoking for this population.
Researcher assumptions revisited.
It is important to revisit the researcher assumptions underlying the development of this
study and how they hold up in light of the findings. These assumptions, based on the researchers’
backgrounds and experiences, were present in all of the decisions that were made along the
process of coding, analyzing, and interpreting the findings. The first assumption was that
physicians would discuss smoking with patients with lung cancer. Overall this assumption was
correct, as three-fourths of our sample asked patients about smoking. However, most of the
transcripts did not necessarily include a lengthy discussion about smoking, but rather the
physician collected information about smoking behaviors by asking questions. The second

64
assumption was that there would be a lot of variation in how the conversation was initiated and
the content within conversations about smoking. However, our findings indicate that there was
not as much variation as previously anticipated, particularly regarding how conversations were
initiated. The researchers were surprised to find that almost every conversation began with a
similar phrase, almost verbatim, to assess patient’s smoking status. Additionally, very few
content categories emerged within coding, and there were many similarities in the language used
across transcripts within these content categories as well. The third assumption was that
physicians would discuss smoking in ways that were linked more explicitly to the lung cancer
diagnosis and potentially use stigmatizing language. However it appears that, for the most part,
physicians engaged in conversation about smoking using a style that would be appropriate for
any patient regardless of disease. The researchers were surprised to find that two-thirds of
physicians did not link smoking conversation with the patient’s disease type or future treatment.
Additionally, while a few physicians used language that displayed a potentially negative bias
toward smoking or those who smoke, the majority of physicians did not use any overtly
stigmatizing language during conversations about smoking.
Implications and Future Directions
This study explored how physicians navigate conversations about smoking with
standardized patients with lung cancer. The findings provide a deeper understanding of how
physicians initiate conversations, what types of statements are included within conversations,
and how physicians provide support for smoking cessation or smoking-related stigma. Overall,
this study highlights that while a majority of physicians ask patients about smoking, it appears
that physicians aim for these conversations to be short, routine, and medically driven.
Conversations about smoking appear not to be tailored to the needs of patients with lung cancer,
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such as the recognition of and support for smoking cessation and smoking-related stigma. This
knowledge may enable physicians to improve their communication about sensitive topics, such
as smoking, to support the goal of continued smoking cessation while assuaging patients’ stigma,
and improve overall patient health outcomes and well-being.
The findings from this study contribute to the research priorities of improving patientcentered communication in cancer care. Understanding how conversations about smoking are
currently navigated may assist physicians and other healthcare providers as they aim to improve
both the physical health and mental well-being of patients with lung cancer. Given the
association between smoking and cancer diagnosis, patients may feel stigmatized during
appointments with physicians. Our findings have implications for physicians who work with
patients with lung cancer by promoting communication training and interventions that address
patients’ concerns. Overall, the findings from our study are in line with prior research in
recommending that physicians receive training for tailoring conversations about smoking
cessation specifically to the needs of patients with lung cancer.
Our study found that a majority of physicians asked patients about smoking during the
initial appointment, which is in line with recommendations to incorporate smoking cessation as a
standard part of cancer care, regardless of stage of cancer or patient’s cessation status (Hanna et
al., 2013; Toll et al., 2013). Including conversations about smoking as a routine part of care
would reduce confusion about the role of physicians in smoking cessation (Conlon et al., 2017).
However, just asking patients about smoking is not as beneficial as providing more intensive
support. Many interventions use the five A’s as recommendations for what physicians should
cover in conversations about smoking: ask about tobacco use, advise all smokers to quit, assess
patient’s willingness to quit, assist patient with quitting, and arrange a follow-up contact (Park et
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al., 2015). While these are a good starting point for physicians to initiate conversations about
smoking, many physicians rely on the less intensive tactics such as ‘Ask’ and ‘Advise’, rarely
spending time to ‘Assist’ and ‘Arrange’, which are shown to be more effective by increasing
odds of cessation up to 40% (Park, 2015). It may be that physicians do not pursue conversations
about smoking far enough to move into these more intensive forms of support, preventing
patients from receiving the type of support deemed more effective (Wells et al., 2017). Our
findings support that many physicians only utilize a few of these tactics; the majority of
physicians in our study only asked about tobacco use.
Physicians may want to implement tactics that are particularly useful for patients with
lung cancer such as, using gain-framed motivation statements, recognizing and providing support
for stigma, and promoting social support for smoking cessation (Cataldo et al., 2010). Using
gain-framed messaging that shares the benefits of quitting rather than risks of continued
smoking, may help reduce feelings of shame and guilt when discussing smoking behaviors
(Hanna et al., 2013; Toll et al., 2013). We found that while physicians in our study did not talk
much about smoking cessation, when they did they used gain-framed messaging rather than
focusing on the risks, which highlights that physicians may already be using skills learned in
communication training. However, physicians in our study missed opportunities to recognize and
address smoking-related stigma or discuss how social support influences smoking cessation.
Further research into these missed opportunities for provision of praise, empathy, and support
should be addressed (i.e. Levinson, Gorawara-Bhat, & Lamb, 2000; Suchman, Markakis,
Beckman, & Frankel, 1997).
Additionally, it may be beneficial for conversations to use language that avoids
expressing judgment and blame, and instead acknowledges the challenges of smoking cessation

67
using open-ended questions to elicit patients’ experiences (Codern-Bové et al., 2014; Simmons et
al., 2009; Toll et al., 2014). It may be ineffective to follow rigidly medical history protocols
when asking about smoking or asking prematurely for behavior change (Codern-Bové et al.,
2014). We found mixed results regarding these conversational behaviors in our study. While
physicians did not use overtly stigmatizing comments, there were also not many comments that
minimized blame or acknowledged the challenges of smoking cessation. Additionally, physicians
actively chose polar questions instead of open-ended questions, and framed discussion about
smoking around charting the medical history. Smoking cessation was discussed in very few
appointments, and we did not observe physicians talking to patients about making behavior
changes such as smoking cessation. Future work should consider how particular conversation
behaviors are used effectively or ineffectively in conversations about smoking with patients with
lung cancer.
Finally, it is important that physicians learn how to appropriately tailor conversations
about smoking to each individual patient, including patients with lung cancer (Cataldo et al.,
2010; Hanna et al., 2013; Toll et al., 2013). Tailoring to patients with lung cancer might include
prescribing cessation medication, scheduling follow-up appointments, discussing patients’ plan
for receiving social support, and providing information about smoking support groups
specifically for patients with lung cancer (Cataldo et al., 2010; Hanna et al., 2013; Toll et al.,
2013). Because many patients attempt to quit smoking many times before continued cessation is
successful, scheduling follow-up appointments and promoting social support is beneficial
(Okuyemi et al., 2006). Tailoring to patients with lung cancer might include teaching physicians
to recognize smoking-related stigma and emotions such as guilt and shame so that they can react
empathically and provide appropriate support. We observed physicians making few negative
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comments about smoking or those who smoke, and making no overtly stigmatizing comments.
This may reflect that physicians are already engaging skills in empathic communication. Some
physicians in our study showed an increased attention to empathic communication skills when
discussing difficult topics such as smoking. However, we recommend that physicians should
recognize and address the role of smoking-related stigma in the context of smoking cessation for
patients with lung cancer.
Taken together, our findings suggest that physicians should receive training in tailoring
conversations about smoking cessation to patients with lung cancer, taking into consideration the
influence smoking-related stigma may have on patient’s health and well-being. Indeed,
physicians report feeling undertrained in this area and share a desire for more training (Conlon et
al., 2017; Wells et al., 2017), and patients report that they want physicians to initiate
conversations and provide support without the shame or guilt that may come with talking about
smoking (Farley et al., 2016; Simmons et al., 2009). Therefore, future research should consider
adding these suggested components to existing communication trainings. For example, it may be
feasible to expand the SCALE (Smoking Cessation within the context of a Lung Cancer
Screening) program to include information about smoking cessation within the context of both a
lung cancer screening and a lung cancer diagnosis (Joseph et al., 2017).
Strengths and Limitations
This study included several strengths regarding the methodology. The Standardized
Patient design allowed for control over patient presentation. All physicians saw a very similar
patient role because actors were trained to present a particular disease and lifestyle. Additionally,
our study included good patient role fidelity along with a low 15% of our physicians detected the
standardized patient. Note: we did not include detected visits in this study. Due to this strong
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control over the patient role and presentation, the conversation prompts by the patients were very
similar across transcripts allowing for dependable comparison. Additionally, our study included
a variety of physicians based on location, race/ethnicity, gender, age and specialty, which allows
for greater generalizability. Finally, the data were obtained using a hidden audio recorder,
providing a level of authenticity to the conversations.
However, the limitations of this study should also be noted. The sample of older male
patients may not generalize to the wider population of patients diagnosed with lung cancer.
Particularly, these findings may not generalize to younger patients, given that our sample may
represent a specific cohort of individuals who lived in a historical context that did not understand
the dangers of smoking until they were older. Our patients were all male; therefore our findings
may not be generalizable to female patients with lung cancer. Additionally, for this particular
study, all of our standardized patients had recently quit smoking as part of their medical history.
Thus, we cannot determine how physicians would respond to patients that had not quit at the
time of the appointment. The use of standardized patients may have limited our ability to see
more variability in physician responses, particularly because the main objective for the
standardized patients in the SBI study, from which this data was drawn, was to discuss and
receive support for cancer associated pain. Therefore, physicians could have been influenced by
the discussion of pain and pain medications by the standardized patient early on, thus affecting
the content and progression of the remainder of the appointment. Another limitation of this study
is that conversations were only observed during the first appointment between a physician and
the patient. Observing physician-patient communication across multiple visits would provide
more substantial and meaningful data. Finally, because the study used transcripts of
conversations rather than physician interviews, we were unable to examine physicians’ thought
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processes during their conversations about smoking. Overall, the study design did not provide
opportunity to assess patient or physician perception of stigma (or support for feeling
stigmatized) associated with conversations about smoking in this investigation.
Conclusion
The aim of this study was to explore how physicians navigate conversations about
smoking with patients with lung cancer, particularly given the association of smoking-related
stigma and lung cancer. This study used qualitative methodology to examine a) how physicians
initiated conversations about smoking, b) how physicians navigated conversations about
smoking, and c) how physicians provided support for smoking cessation and smoking-related
stigma. The findings from this study offer insight into how physicians navigate conversations
about smoking with patients with lung cancer, which is a topic seldom addressed in the current
literature on lung cancer. Our findings cannot provide evaluation regarding what aspects of
conversations are “good” or “bad”; further research is needed to understand what implications
these conversations have on patient and physician attitudes, perceptions, and decisions.
However, our findings illustrate the importance of future research that examines conversations
about smoking with patients with lung cancer. Our study revealed that conversations about
smoking were typically short and not overtly tailored for patients with a lung cancer diagnosis.
Further, physicians asked patients about smoking in a majority of transcripts (75%), but not all of
them. Since patients with lung cancer have a unique context, including the strong association
between smoking behaviors and the disease that may increase feelings of stigma or guilt (Shen et
al., 2016; Tod & Joanne, 2010), it is important for physicians to initiate conversations about
smoking with all patients with lung cancer and tailor their approach to these distinct issues
during conversations about smoking.
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Additionally, our study revealed that physicians did not offer tangible support for
smoking cessation or smoking-related stigma, such as medications or support group information.
Given that smoking cessation is beneficial to both physical health and mental well-being during
cancer treatment (Cataldo et al., 2010; Gemine & Lewis, 2017), and given that cessation rates are
higher with physician support (Stead et al., 2013), this is an important topic for physicians to
initiate. Considering that patients with lung cancer report higher rates of stigma and guilt than
patients with other cancers (Carter-Harris et al., 2014; Lebel et al., 2013), recognizing and
addressing smoking-related stigma concerns and providing emotional support is an important
part of medical treatment (Cataldo et al., 2010; Epstein & Street Jr., 2007). All of these
recommendations are put forth with the ultimate goal to help patients with lung cancer have
positive physical health outcomes and mental well-being through providing both tangible and
intangible supports for addressing targeted goals such as smoking cessation while minimizing
negative impacts of smoking-related stigma.
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TABLES

Table 1. SBI Study Sample Description (N = 96)
%/Mean
Physician race (white)
64%
Specialty (oncologist)
47%
Physician sex (male)
59%
Physician age
52.1
Note: missing data for 2 physicians

SD

12

Table 2. Dissertation Study Sample Description (N=56)

Physician race (white)
Physician race (South Asian)
Specialty (oncologist)
Physician sex (male)
Physician age
Note: missing data for 2 physicians

%/Mean
52%
32%
47%
64%
54.2

SD

13
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Table 3. Qualitative Analytic Process
Step

Qualitative Analytic Process

Step 1

Review and Explore Data
-Identify “Big Ideas”
-Organize data into categories for coding

Step 2

First Cycle Coding: Initial Coding & Revising Scheme
4
-Descriptive, process, and holistic
-Create memos and summary tables
-Check inter-rater reliability
-Add, eliminate, collapse codes as needed
Second Cycle Axial Coding
2
-Identify patterns, clusters, or frequencies in data
-Compare and contrast cases
Interpret Findings
2
-Analyze and synthesize findings by linking to experience,
insight, and literature

Step 3
Step 4

Number of
researchers
4
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Table 4. Qualitative Coding Categories
Original Codes

Refined Categories

1) Assesses patient smoking history

1) Assesses patient smoking status
2) Builds a profile of smoking history
3) Praises smoking cessation

2) Praises patient for quitting
3) Provides information on benefits of cessation
4) Provides empathy or understanding

4) Provides empathy or understanding

5) Relates smoking behavior to treatment options

5) Connects smoking behaviors to
diagnosis or treatment

6) Relates smoking behavior to diagnosis
7) Discounts patient’s previous attempts to quit

6) Presents a negative bias about
smoking

8) Makes a statement that may be perceived as
stigmatizing
9) Makes a statement that may be perceived as Removed:
counter-stigmatizing
All codes in this category were either
under praise or empathy/understanding
10) Asks patient about motivation to quit
Removed:
This category was filed under building
smoking history profile
11) Asks about family history of smoking
Removed:
This category was filed under building
smoking history profile
12) Shares own/others smoking history
Removed:
Occurred in less than 5 physicians
13) Shares ideas for smoking cessation
Removed:
Occurred in less than 5 physicians
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FIGURES

Assessed for eligibility (n=111)
Excluded (n=10)
• Knew hypotheses (2), moved (1),
retired (1), too busy (1), withdrew (5)

Randomized (n=101)

Allocation (n=96)
Allocated to White SPs (n= 50)

Allocated to Black SPs (n= 51)
•
•

Completed at least 1 SP visit (n= 48)
Did not complete at least 1 SP visit (3) &
problem scheduling (3)

•
•

Completed at least 1 SP visit (48)
Did not complete at least 1 SP visit (2),
withdrew (1), & problem scheduling (1)

Analysis (n=58)
Analyzed (n=33)
•
•

Detected SP (8)
Did not discuss smoking (7)

Figure 1. Qualitative Analysis Diagram

Analyzed (n=25)
•
•

Detected SP (13)
Did not discuss smoking (10)
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